US20020012971A1 - PCR compatible nucleic acid sieving medium - Google Patents
PCR compatible nucleic acid sieving medium Download PDFInfo
- Publication number
- US20020012971A1 US20020012971A1 US09/792,297 US79229701A US2002012971A1 US 20020012971 A1 US20020012971 A1 US 20020012971A1 US 79229701 A US79229701 A US 79229701A US 2002012971 A1 US2002012971 A1 US 2002012971A1
- Authority
- US
- United States
- Prior art keywords
- pcr
- polymer
- polymer solution
- sieving medium
- sieving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007873 sieving Methods 0.000 title claims abstract description 121
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 73
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 72
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 72
- 229920000642 polymer Polymers 0.000 claims abstract description 95
- 238000000926 separation method Methods 0.000 claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims description 72
- 108091033319 polynucleotide Proteins 0.000 claims description 26
- 102000040430 polynucleotide Human genes 0.000 claims description 26
- 239000002157 polynucleotide Substances 0.000 claims description 26
- -1 hydroxycellulose Polymers 0.000 claims description 22
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 229920002401 polyacrylamide Polymers 0.000 claims description 11
- 229920000936 Agarose Polymers 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 6
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 6
- 229920000609 methyl cellulose Polymers 0.000 claims description 6
- 239000001923 methylcellulose Substances 0.000 claims description 6
- 235000010981 methylcellulose Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 239000012807 PCR reagent Substances 0.000 claims description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 100
- 239000012530 fluid Substances 0.000 description 71
- 239000002609 medium Substances 0.000 description 69
- 239000000047 product Substances 0.000 description 35
- 239000000499 gel Substances 0.000 description 26
- 239000000463 material Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 229920005989 resin Polymers 0.000 description 17
- 239000011347 resin Substances 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 239000011159 matrix material Substances 0.000 description 16
- 239000000975 dye Substances 0.000 description 14
- 238000010438 heat treatment Methods 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 239000000178 monomer Substances 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 239000013615 primer Substances 0.000 description 10
- 239000002987 primer (paints) Substances 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- 238000006116 polymerization reaction Methods 0.000 description 9
- 150000001412 amines Chemical class 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 238000003556 assay Methods 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 238000005370 electroosmosis Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000007834 ligase chain reaction Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000003926 acrylamides Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012809 cooling fluid Substances 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 2
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 229930006711 bornane-2,3-dione Natural products 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 2
- UKZQEOHHLOYJLY-UHFFFAOYSA-M ethyl eosin Chemical compound [K+].CCOC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 UKZQEOHHLOYJLY-UHFFFAOYSA-M 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000003819 low-pressure liquid chromatography Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930187593 rose bengal Natural products 0.000 description 2
- 229940081623 rose bengal Drugs 0.000 description 2
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- LGPAKRMZNPYPMG-UHFFFAOYSA-N (3-hydroxy-2-prop-2-enoyloxypropyl) prop-2-enoate Chemical compound C=CC(=O)OC(CO)COC(=O)C=C LGPAKRMZNPYPMG-UHFFFAOYSA-N 0.000 description 1
- PSGCQDPCAWOCSH-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) prop-2-enoate Chemical compound C1CC2(C)C(OC(=O)C=C)CC1C2(C)C PSGCQDPCAWOCSH-UHFFFAOYSA-N 0.000 description 1
- OAKFFVBGTSPYEG-UHFFFAOYSA-N (4-prop-2-enoyloxycyclohexyl) prop-2-enoate Chemical compound C=CC(=O)OC1CCC(OC(=O)C=C)CC1 OAKFFVBGTSPYEG-UHFFFAOYSA-N 0.000 description 1
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 description 1
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- BKSGFAOLZOVJSI-UHFFFAOYSA-N 2,2-dimethoxy-2-phenoxy-1-phenylethanone Chemical compound C=1C=CC=CC=1C(=O)C(OC)(OC)OC1=CC=CC=C1 BKSGFAOLZOVJSI-UHFFFAOYSA-N 0.000 description 1
- PUGOMSLRUSTQGV-UHFFFAOYSA-N 2,3-di(prop-2-enoyloxy)propyl prop-2-enoate Chemical compound C=CC(=O)OCC(OC(=O)C=C)COC(=O)C=C PUGOMSLRUSTQGV-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- XNIOWJUQPMKCIJ-UHFFFAOYSA-N 2-(benzylamino)ethanol Chemical compound OCCNCC1=CC=CC=C1 XNIOWJUQPMKCIJ-UHFFFAOYSA-N 0.000 description 1
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 1
- SZTBMYHIYNGYIA-UHFFFAOYSA-M 2-chloroacrylate Chemical compound [O-]C(=O)C(Cl)=C SZTBMYHIYNGYIA-UHFFFAOYSA-M 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- NKXVNGNOUBMWRQ-UHFFFAOYSA-N 2-methoxy-2-phenoxy-1-phenylethanone Chemical compound C=1C=CC=CC=1C(=O)C(OC)OC1=CC=CC=C1 NKXVNGNOUBMWRQ-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- HTWRFCRQSLVESJ-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCOC(=O)C(C)=C HTWRFCRQSLVESJ-UHFFFAOYSA-N 0.000 description 1
- GFLJTEHFZZNCTR-UHFFFAOYSA-N 3-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OCCCOC(=O)C=C GFLJTEHFZZNCTR-UHFFFAOYSA-N 0.000 description 1
- QEQSQRMXBUILTG-UHFFFAOYSA-N 4,5-dihydroxyocta-2,6-dienediamide Chemical compound NC(=O)C=CC(O)C(O)C=CC(N)=O QEQSQRMXBUILTG-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000105975 Antidesma platyphyllum Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 101150027068 DEGS1 gene Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- 238000011021 bench scale process Methods 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- YMQUHROOFPZMRB-UHFFFAOYSA-N butane-1,2,4-triol;2,3-dimethylbut-2-enoic acid Chemical compound OCCC(O)CO.CC(C)=C(C)C(O)=O YMQUHROOFPZMRB-UHFFFAOYSA-N 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 229920003237 carborane-containing polymer Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N dimethylmethane Natural products CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000000198 fluorescence anisotropy Methods 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000009424 haa Nutrition 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000012188 high-throughput screening assay Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- LYBKPDDZTNUNNM-UHFFFAOYSA-N isopropylbenzylamine Chemical compound CC(C)NCC1=CC=CC=C1 LYBKPDDZTNUNNM-UHFFFAOYSA-N 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- YYGBVRCTHASBKD-UHFFFAOYSA-M methylene green Chemical compound [Cl-].C1=CC(N(C)C)=C([N+]([O-])=O)C2=[S+]C3=CC(N(C)C)=CC=C3N=C21 YYGBVRCTHASBKD-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- ZMLXKXHICXTSDM-UHFFFAOYSA-N n-[1,2-dihydroxy-2-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NC(O)C(O)NC(=O)C=C ZMLXKXHICXTSDM-UHFFFAOYSA-N 0.000 description 1
- DJVKJGIZQFBFGS-UHFFFAOYSA-N n-[2-[2-(prop-2-enoylamino)ethyldisulfanyl]ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCSSCCNC(=O)C=C DJVKJGIZQFBFGS-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- QTECDUFMBMSHKR-UHFFFAOYSA-N prop-2-enyl prop-2-enoate Chemical compound C=CCOC(=O)C=C QTECDUFMBMSHKR-UHFFFAOYSA-N 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Definitions
- Manipulating fluidic reagents and assessing the results of reagent interactions are central to chemical and biological science. Manipulations include mixing fluidic reagents, assaying products resulting from such mixtures, separation or purification of products and reagents, and the like. A single experiment may involve hundreds of fluidic manipulations, product separations, recording processes and the like, each of which involve different types of laboratory equipment and conditions.
- PCR polymerase chain reaction
- microscale devices for high throughput mixing and assaying small fluid volumes have been developed. See, e.g., Parce et al., U.S. Pat. No. 5,942,443, “High Throughput Screening Assay Systems in Microscale Devices,” which provides pioneering technology related to microscale devices.
- U.S. Ser. No. 09/093,832 by Burd Mehta et al. “Microfluidic Matrix Localization Apparatus and Methods,” provides methods of performing PCR and nucleic acid separations in the same microfluidic device.
- Improved methods for performing PCR and nucleic acid separations including improved sieving mediums are desirable, particularly those which take advantage of high-throughput, low cost microfluidic systems.
- the present invention provides these and other features by providing nucleic acid sieving mediums, methods of performing PCR and nucleic acid separations along with high throughput microscale systems and many other features that will be apparent upon complete review of the following disclosure.
- the present invention provides nucleic acid sieving mediums, microfluidic devices, and methods for performing nucleic acid separations and PCR.
- the sieving mediums provided are compatible with both nucleic acid separations and PCR because they provide baseline nucleic acid separation and do not inhibit PCR.
- a microfluidic device for performing both PCR and nucleic acid separations.
- the device comprises at least one microscale channel and a sieving medium.
- the sieving medium is disposed within the at least one microscale channel and comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less.
- Typical polymers include acrylamide, such as linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, and the like.
- Other polymers include, but are not limited to, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, and the like.
- the devices also optionally comprise one or more proteins, nucleic acids, PCR reaction components, or PCR products disposed within the at least one microfluidic channel.
- PCR reaction components include, but are not limited to, a polymerase, e.g., a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, and Mg ++ .
- the method comprises providing two or more polynucleotides and a sieving medium.
- the polynucleotides typically comprise one or more PCR products, RNA, or DNA.
- the sieving medium typically comprises a polymer solution as described above. The two or more polynucleotides migrate through the sieving medium, thereby separating the two or more polynucleotides.
- the sieving medium is introduced into a microfluidic channel and the two or more polynucleotides migrate through the sieving medium in the microfluidic channel.
- the two or more polynucleotides are optionally separated by electrophoresis in the sieving medium.
- methods of performing PCR and separating one or more PCR products comprise mixing one or more PCR reaction component as described above with a sieving medium to provide a PCR sieving medium, wherein the sieving medium comprises a polymer solution as described above.
- the PCR sieving medium is then thermocycled to produce one or more PCR products, which are separated by flowing in the sieving medium.
- PCR is performed in a microfluidic device by mixing the PCR reaction components with the sieving medium in a microfluidic channel.
- the one or more PCR products are separated, e.g., electrophoretically, by flowing the one or more PCR products through the sieving medium in the microfluidic channel.
- nucleic acid sieving mediums comprise one or more polynucleotides, such as DNA, RNA, PCR products, or the like, one or more PCR reagents as described above, and a polymer solution as described above.
- FIG. 1 is a schematic drawing of a microfluidic device for performing PCR and nucleic acid separations.
- FIG. 2 is a schematic drawing of a microchannel for joule heating.
- FIG. 3 is a graph providing nucleic acid separation data obtained in a sieving medium comprising 0.35% polymer.
- DNA separations are normally performed in sieving mediums that have a certain concentration of sieving medium to achieve separation of various sizes of DNA fragments.
- concentration of polymers used in sieving media typically inhibits the polymerase chain reaction (PCR), thereby preventing the two assays from being carried out in one medium.
- the present invention provides a mixture compatible with PCR that also serves as a DNA separation medium.
- the sieving mediums of the present invention comprise lower concentrations of polymer than are normally used to achieve DNA separation. The lower concentrations of polymer do not inhibit PCR and still provide separation of polynucleotides.
- a typical sieving polymer concentration used in DNA separations is about 3%, e.g., 3% acrylamide. This concentration is known to inhibit polymerase chain reactions (PCR). However, lower levels of the same polymer are not inhibitory.
- the present invention provides a PCR compatible mixture with a low amount of polymer used to suppress electroosmotic flow in the channels of a microfluidic device.
- the concentration of polymer provided in the present invention is typically less than about 0.5%, more typically less than about 0.4% and preferably about 0.35% or less. Since this is below the usual threshold of sieving, the polymer here was initially used as an agent to eliminate bulk movement of the fluid by acting as a dynamic coating for the channel walls.
- the present sieving medium also provided nucleic acid separations in the same low polymer medium in which PCR was performed. While, the exact mechanism of DNA sieving is not known, one advantage of the present medium is to provide a single fluid compatible with PCR and nucleic acid separations. Thus, the present invention provides, with a relatively simple loading or fabrication procedure, multi-step assays, e.g., PCR and subsequent product separation, using the present sieving medium.
- the present invention provides a nucleic acid sieving medium compatible with nucleic acid separations and PCR as well as devices for performing nucleic acid separations and PCR, e.g., devices comprising a sieving medium with a low polymer concentration. Methods of separating nucleic acids and performing PCR using low concentration sieving mediums are also provided.
- a nucleic acid sieving medium that is compatible with PCR and nucleic acid separations is provided.
- the sieving medium comprises a low concentration of polymer, which low concentration does not inhibit PCR.
- DNA is separated in sieving mediums with higher polymer concentrations than those provided herein.
- nucleic acids are optionally separated using the lower polymer concentrations provided herein thereby providing methods for performing nucleic acid separation and PCR in the same medium.
- the sieving medium typically comprises one or more polynucleotides, one or more PCR reagents, and a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less.
- the polymer solution is thereby used to provide PCR and nucleic acid separations in the same matrix.
- the polymer solution is eliminated and optionally replaced with an electroosmotic flow suppressor.
- the one or more PCR reaction components comprise one or more of: a thermostable polymerase, a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, Mg ++ , and the like.
- the one or more polynucleotides typically comprise DNA, RNA, or PCR products.
- Typical polymer solutions of the invention comprise low concentrations of one or more of the following: acrylamide, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, or the like. Combinations of any of these polymers are also optionally used.
- acrylamide Various types of acrylamide are used, including, but not limited to, linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, or the like.
- a wide variety of alternative sieving mediums are available, and are optionally used in methods of the invention, e.g., at low concentrations to provide a medium compatible with both PCR and nucleic acid separations.
- a variety of sieving matrixes and the like are available from Supelco, Inc. (Bellefonte, Pa.; see, 1997 Suppleco catalogue).
- Common matrixes which are useful in the present invention include those generally used in low pressure liquid chromatography, gel electrophoresis and other liquid phase separations; matrix materials designed primarily for non-liquid phase chromatography are also useful in certain contexts, as the materials often retain separatory characteristics when suspended in fluids.
- Alternate separation matrix media include, but are not limited to, low pressure liquid chromatography media include, e.g., non-ionic macroreticular and macroporous resins which adsorb and release components based upon hydrophilic or hydrophobic interactions such as Amberchrom resins (highly cross-linked styrene/divinylbenzene copolymers suitable for separation of peptides, proteins, nucleic acids, antibiotics, phytopharmacologicals, and vitamins); the related Amberlite XAD series resins (polyaromatics and acrylic esters) and amberchroms (polyaromatic and polymethacrylates) (manufactured by Rohm and Haas, available through Suppleco); Diaion (polyaromatic or polymethacrylic beads); Dowex (polyaromatics or substituted hydrophilic functionalized polyaromatics) (manufactured by Dow Chemical, available through Suppleco); Duolite (phenol-formaldehy
- Other electrophoresis media include silica gels such as Davisil Silica, E. Merck Silica Gel, Sigma-Aldrich Silica Gel (all available from Suppleco) in addition to a wide range of silica gels available for various purposes as described in the Aldrich catalogue/handbook (Aldrich Chemical Company (Milwaukee, Wis.)).
- Preferred gel materials include agarose based gels, various forms of acrylamide based gels, Genescan polymers (reagents available from, e.g., Suppleco, SIGMA, Aldrich, SIGMA-Aldrich and many other sources), colloidial solutions such as protein colloids (gelatins) and hydrated starches.
- colloidial solutions such as protein colloids (gelatins) and hydrated starches.
- affinity media for purification and separation of molecular components are also available, including a variety of modified silica gels available from SIGMA, Aldrich and SIGMA-Aldrich, as well as Suppleco, such as acrylic beads, agarose beads, cellulose, sepharose, sepharose CL, toyopearl, or the like chemically linked to an affinity ligand such as a biological molecule.
- modified silica gels available from SIGMA, Aldrich and SIGMA-Aldrich
- Suppleco such as acrylic beads, agarose beads, cellulose, sepharose, sepharose CL, toyopearl, or the like chemically linked to an affinity ligand such as a biological molecule.
- activated matrixes amino acid resins, avidin and biotin resins, carbohydrate resins, dye resins, glutathione resins, hydrophobic resins, immunochemical resins, lectin resins, nucleotide/coenzyme resins, nucleic acid resins, and specialty resins are available, e.g., from Suppleco, SIGMA, Aldrich or the like. See also, Hermanson et al. (1992) Immobilized Affinity Ligand Techniques Academic Press and optionally used in the channels of the invention.
- the fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer).
- the fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired.
- Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure.
- free-radical polymerizable monomers photopolymerize to form gels, or can be made photopolymerizeable by the addition of, e.g., energy transfer dyes.
- free-radical polymerizable monomers can be selected from acrylate, methacrylate and vinyl ester functionalized materials. They can be monomers and/or oligomers such as (meth)acrylates (meth)acrylamides, acrylamides, vinyl pyrrolidone and azalactones.
- Such monomers include mono-, di-, or poly-acrylates and methacrylates such as methyl acrylate, methyl methacrylate, ethyl acrylate, isopropyl methacrylate, isooctyl acrylate, isobornyl acrylate, isobornyl methacrylate, acrylic acid, n-hexyl acrylate, stearyl acrylate, allyl acrylate, glycerol diacrylate, glycerol triacrylate, ethylene glycol diacrylate, diethyleneglycol diacrylate, triethyleneglycol dimethacrylate, 1,6-hexanediol diacrylate, 1,3-propanediol diacrylate, 1,3-propanediol dimethacrylate, trimethanol triacrylate, 1,2,4-butanetriol trimethylacrylate, 1,4-cyclohexanediol diacrylate, pentaerythritol triacrylate, pen
- Strongly polar monomers such as acrylic acid, acrylamide, itaconic acid, hydroxyalkyl acrylates, or substituted acrylamides or moderately polar monomers such as N-vinyl-2-pyrrolidone, N-vinyl caprolactam, and acrylonitrile are also useful.
- Proteins such as gelatin, collagen, elastin, zein, and albumin, whether produced from natural or recombinant sources, which are made by free-radical polymerization by the addition of carbon-carbon double or triple bond-containing moieties, including acrylate, diacrylate, methacrylate, ethacrylate, 2-phenyl acrylate, 2-chloro acrylate, 2-bromo acrylate, itaconate, oliogoacrylate, dimethacrylate, oligomethacrylate, acrylamide, methacrylamide, styrene groups, and other biologically acceptable photopolymerizable groups, can also be used, e.g., in low concentration, to form sieving matrixes.
- moieties including acrylate, diacrylate, methacrylate, ethacrylate, 2-phenyl acrylate, 2-chloro acrylate, 2-bromo acrylate, itaconate, oliogoacrylate, dimethacrylate, o
- Dye-sensitized polymerization is well known in the chemical literature.
- light from an argon ion laser (514 nm) in the presence of an xanthin dye and an electron donor, such as triethanolamine, to catalyze initiation, serves to induce a free radical polymerization of acrylic groups in a reaction mixture (Neckers, et al., (1989) Polym. Materials Sci. Eng., 60:15; Fouassier, et al., (1991) Makromol. Chem., 192:245-260).
- the dye After absorbing laser light, the dye is excited to a triplet state.
- the triplet state reacts with a tertiary amine such as the triethanolamine, producing a free radical which initiates a polymerization reaction.
- Polymerization is extremely rapid and is dependent on the functionality of the composition, its concentration, light intensity, and the concentration of dye and, e.g., amine.
- Dyes are also optionally used which absorb light having a frequency between 320 nm and 900 nm, form free radicals, are water soluble, etc.
- photosensitive dyes that are optionally used to optically initiate polymerization, such as ethyl eosin, eosin Y, fluorescein, 2,2-dimethoxy-2-phenyl acetophenone, 2-methoxy,2-phenylacetophenone, camphorquinone, rose bengal, methylene blue, erythrosin, phloxime, thionine, riboflavin, methylene green, acridine orange, xanthine dye, and thioxanthine dyes.
- Cocatalysts useful with photoinitiating dyes are typically nitrogen based compounds capable of stimulating a free radical reaction.
- Primary, secondary, tertiary or quaternary amines are suitable cocatalysts, as are nitrogen atoms containing electron-rich molecules.
- Cocatalysts include triethanolamine, triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethyl benzylamine, dibenzyl amine, N-benzyl ethanolamine, N-isopropyl benzylamine, tetramethyl ethylenediamine, potassium persulfate, tetramethyl ethylenediamine, lysine, ornithine, histidine and arginine.
- Examples of the dye/photoinitiator system include ethyl eosin with an amine, eosin Y with an amine, 2,2-dimethoxy-2-phenoxyacetophenone, 2-methoxy-2-phenoxyacetophenone, camphorquinone with an amine, and rose bengal with an amine.
- dye may absorb light and initiate polymerization, without any additional initiator such as an amine.
- additional initiator such as an amine.
- only the dye and a monomer need be present to initiate polymerization upon exposure to light. The generation of free radicals is terminated when the laser light is removed.
- Some photoinitiators such as 2,2-dimethoxy-2-phenylacetophenone, do not require any auxiliary amine to induce photopolymerization; in these cases, the presence of dye, monomer, and an appropriate wavelength of light is sufficient for photopolymerization.
- Preferred light sources include various lamps and lasers such as those which have a wavelength of about 320-800 nm.
- This light can be provided by any appropriate source able to generate the desired radiation, such as a mercury lamp, longwave UV lamp, He-Ne laser, an argon ion laser, etc.
- a UV source is used to polymerize a UV photopolymerizeable gel.
- the light source used is typically selected based upon the chemistry which is to be affected by the source.
- a variety of gels or polymers are selectively polymerized by exposure to heat.
- selective heat control using applied current is easily performed in the microfluidic apparatus of the invention, providing for simplified control of gel polymerization through thermal processes. Examples include initiation by thermal initiators, which form free radicals at moderate temperatures, such as benzoyl peroxide, with or without triethanolamine, potassium persulfate, with or without tetramethylethylenediamine, and ammonium persulfate with sodium bisulfite.
- the fluid is polymerized by selectively exposing it to an activator or cross-linker.
- an activator or cross-linker for example, where the fluid is polyacrylamide, the activator/cross linker can be TEMED and/or APS.
- the above polymers e.g., in solution format, gel format, or the like, and typically polymerized as described above, are typically used in microfluidic devices to provide devices useful for both PCR and separation of nucleic acids.
- a mixture of polynucleotides e.g., DNA or RNA molecules or fragments thereof, PCR products, sequencing reaction products, and the like, are separated by size and/or charge in a sieving medium, e.g., a sieving medium as described above.
- the separation is typically an electrophoretic separation.
- the separated products are detected, often as they pass a detector (nucleic acids are typically labeled with radioactive nucleotides or fluorophores; accordingly appropriate detectors include spectrophotometers, fluorescent detectors, microscopes (e.g., for fluorescent microscopy) and scintillation counting devices).
- a sequencing reaction e.g., a chain termination method of sequencing
- detection of size separated products is used to compile sequence information for the region being sequenced.
- Electrophoretic separation is the separation of substances achieved by applying an electric field to samples in a solution or gel, e.g., a polymer solution. In its simplest form, it depends on the different velocities with which the substances or components move in the field. The velocities depend, e.g., on the charge and size of the substances.
- the polynucleotides are separated in a microscale separation channel or capillary.
- the separation channels or regions typically comprise a separation matrix, e.g., a polymerized sieving medium as discussed above.
- the sieving medium optionally comprises a gel or solution.
- the concentration of the polymer in the separation gel or solution is less than about 0.5%.
- the concentration of the sieving medium is less than about 0.4% and more typically about 0.35% or less.
- the polymer concentration can be greater than 0.5%, e.g., 0.55%, 0.6% or higher. See e.g., U.S. Ser. No. 09/093,832 by Burd Mehta et al.
- the channel such as channel 103 in FIG. 1, is a polyacrylamide gel filled channel or a polydimethylacrylamide/co-acrylic acid polymer filled channel on which the mixture of components is electrophoretically separated based on charge/mass ratio or molecular weight.
- Polyacrylamide used as a separation matrix in a microfluidic channel is optionally cross-linked or non-cross-linked.
- it is linear polyacrylamide, i.e., polydimethylacrylamide, polydimethylacrylamide/co-acrylic acid, or the like.
- Other polymers include cellulose, agarose, Genescan polymers, and the like.
- a detector is optionally positioned so that it detects the polynucleotides, e.g., polynucleotides that are stained in the gel with a fluorescent nucleic acid stain. If the components are detected as they exit the separation region, the components are optionally identified by their retention times. The retention time of the oligonucleotides as they are electrophoresed through the sieving medium is used, e.g., in combination with markers to measure the molecular weight of and identify the polynucleotides.
- FIG. 3 demonstrates baseline separation of polynucleotides achieved using the low polymer concentration sieving mediums of the present invention, e.g., a sieving medium comprising 0.35% polymer.
- PCR can be performed in the same sieving matrix used to separate nucleic acids.
- PCR is optionally performed in the presence of a low polymer sieving matrix, and the products of the PCR reaction are separable in the same sieving matrix, e.g., in a microfluidic channel.
- the invention provides new methods of performing PCR.
- components of a PCR reaction mixture i.e., the molecules which participate in a PCR reaction, such as PCR extension primers, nucleotide triphosphates, thermostable enzymes, ions and buffer components such as Mg ++ , template DNAs, etc.
- a sieving medium comprising less than about 0.5% polymer to provide a PCR sieving medium.
- the sieving medium comprises less than about 0.4% polymer.
- the sieving medium comprises about 0.35% polymer or less.
- the sieving medium can comprise more than 0.5% polymer.
- the resulting mixture e.g., the PCR sieving medium
- Sieving mediums of use in performing PCR e.g., with nucleic acid separation of the products, are described above.
- the most common form of in vitro amplification i.e., PCR amplification, generally involves the use of one strand of the target nucleic acid sequence, e.g., the sequence to be amplified, as a template for producing a large number of complements to that sequence.
- PCR amplification generally involves the use of one strand of the target nucleic acid sequence, e.g., the sequence to be amplified, as a template for producing a large number of complements to that sequence.
- two primer sequences complementary to different ends of a segment of the complementary strands of the target sequence hybridize with their respective strands of the target sequence, and in the presence of polymerase enzymes and nucleoside triphosphates, the primers are extended along the target sequence through the action of the polymerase enzyme (in asymmetric PCR protocols, a single primer is used).
- PCR amplification typically involves repeated cycles of denaturation, hybridization and extension reactions to produce sufficient amounts of the target nucleic acid, all of which are carried out at different temperatures.
- melting of the strands, or heat denaturation involves temperatures ranging from about 90° C. to 100° C. for times ranging from seconds to minutes.
- the temperature is then cycled down, e.g., to between about 40° C. and 65° C. for annealing of primers, and then cycled up to between about 70° C. and 85° C. for extension of the primers along the target strand. This process if referred to herein as “thermocycling.”
- RNA polymerase mediated techniques e.g., NASBA
- PCR polymerase chain reaction
- LCR ligase chain reaction
- NASBA RNA polymerase mediated techniques
- the PCR reactants are mixed with a sieving medium comprising a low polymer concentration, e.g., 0.5% or less.
- the products are then directly separated, e.g., in a capillary, using the same sieving medium.
- the components of the PCR reaction mixture e.g., a polymerase, nucleotides, and the like
- a sieving medium e.g., with a low polymer concentration
- the apparatus optionally includes one or more additional channels crossing the microfluidic channel and optionally includes fluid (or joule heating) means such as an electrokinetic controller for thermocycling and fluid direction systems, e.g., electrokinetic controllers and/or pressure sources such as vacuum sources, for flowing materials and reagents through the channels.
- the PCR products are typically electrophoresed through the channels in the same sieving medium used to achieve product separation. Detection regions in the channels and corresponding detectors are also used, e.g., to detect the separated products.
- Microfluidic devices comprising a PCR compatible nucleic acid sieving medium
- the sieving medium of the invention is typically used in a microfluidic device and the separation and PCR methods described above are preferably performed in a microfluidic device.
- the sieving medium is typically polymerized in a microscale channel of a microfluidic device, e.g., after the PCR reaction.
- dynamic sieving mediums such as Genescan polymers, are used that do not require polymerization in the channel.
- PCR and separation of the products are both optionally performed in a sieving medium of the present invention in the channels of a microfluidic device.
- microfluidic devices are optionally adapted for use in the present invention, e.g., by designing and configuring the channels as discussed below. These devices are described in various PCT applications and issued U.S. Patents by the inventors and their coworkers, including U.S. Pat. Nos. 5,699,157 (J. Wallace Parce) issued Dec. 16, 1997, 5,779,868 (J. Wallace Parce et al.) issued Jul. 14, 1998, 5,800,690 (Calvin Y. H. Chow et al.) issued Sep. 1, 1998, 5,842,787 (Anne R. Kopf-Sill et al.) issued Dec. 1, 1998, 5,852,495 (J. Wallace Parce) issued Dec.
- One aspect of the invention is the placement of the sieving medium in selected channels or channel regions of a microfluidic substrate.
- These materials or precursors of the materials, e.g., monomers polymerized in the device as discussed above) are loaded into microfluidic components by electrokinesis, by pressurized pumping, by centrifugal force, or capillary flow.
- the present invention provides methods of DNA separation and PCR that are both compatible with the sieving mediums of the invention. Therefore, the sieving medium is typically loaded throughout the entire device. However if other assays are steps are desired, e.g., DNA sequencing reactions, certain channels are optionally filled with reagents for the desired assay or left empty.
- a sieving medium e.g., in an unpolymerized solution that, upon polymerization, forms a sieving matrix.
- Elements of the microfluidic device such as microfluidic channels are filled with the sieving medium by forcing the fluid into the channel under pressure, or by moving the fluid into the channel electrokinetically.
- the first fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer). The fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired. Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure.
- monomer is pumped, e.g., in aqueous buffer, into a channel or channel region using electroosmotic flow, or using a pressure gradient.
- electroosmotic flow e.g., aqueous buffer
- pressure gradient e.g., a pressure gradient
- a sieving matrix is deposited throughout a channel or channels of a microfluidic device in a form which is subject to electroosmosis (i.e., the matrix moves electrokinetically in the channel).
- a sieving medium is loaded into multiple channels of a microfluidic device, e.g., under pressure, and polymerized in place.
- Selective components which solubilize the polymerized gel are then loaded (e.g., electrokinetically or under pressure) into channel regions where polymerized product is not desired, i.e., channels in which other assays are to be performed.
- the selected components dissolve the polymerized gel.
- Example of solubilization compounds include acids, bases and other chemicals.
- at least two compounds are used to dissolve polymerized products, where both products need to be present to dissolve the polymer. This provides for fine control of dissolution, e.g., where each chemical is under separate electrokinetic control.
- DTT N,N′-bis(acrylol)cystamine or (1,2-dihydroxyethylene-bis-acrylamide) [DHEBA] and sodium periodiate or calcium alginate+EDTA or TCEP-HCL and N,N′-bis(acryloyl)cystamine.
- DHEBA (1,2-dihydroxyethylene-bis-acrylamide)
- sodium periodiate or calcium alginate+EDTA or TCEP-HCL and N,N′-bis(acryloyl)cystamine A variety of such materials are known.
- the sieving medium of the invention is particularly useful for performing experimental or diagnostic procedures which combine nucleic acid amplification and product separatory aspects. For example, PCR is performed in a microfluidic channel comprising a sieving medium as described herein, followed by separation in the same sieving medium, e.g., in the same or in a different channel region.
- PCR or other thermal reaction reagents such as thermostable polymerase, DNA template, primers, nucleotides and buffers are mixed, e.g., with a sieving medium, in a microchannel or chamber, with the entire microfluidic substrate (e.g., a LABCHIPTM from Caliper Technologies) being subject to repeated cycles of heating and cooling, e.g., on a thermocycler or by switching between a hot plate and a heat sink.
- a sieving medium e.g., a LABCHIPTM from Caliper Technologies
- variations in channel thickness and/or voltage are used selectively to heat selected regions of a channel which contain a PCR reaction.
- PCR amplification is particularly well suited to this use in the apparatus, methods and systems of the invention.
- Thermocycling amplification methods including PCR and LCR, are conveniently performed in microscale devices, making iterative fluidic operations involving PCR well suited to use in methods and devices of the present invention (see also, U.S. Pat. Nos. 5,498,392 and 5,587,128 to Willingham et al.).
- generation of amplicons such as sequencing templates using PCR, or direct sequencing of nucleic acids by PCR (e.g., using nuclease digestion as described supra) is performed with the integrated systems and devices of the invention.
- thermocycling in microscale devices including thermocycling by joule heating is described in WO 99/12016, entitled “ELECTRICAL CURRENT FOR CONTROLLING FLUID PARAMETERS IN MICROCHANNELS” published Mar. 11, 1999 by Calvin Chow, Anne R. Kopf-Sill and J. Wallace Parce; in 08/977,528, filed Nov. 25, 1997; in WO 98/45481, entitled “CLOSED-LOOP BIOCHEMICAL ANALYZERS,” published Oct. 15, 1998; and in 09/287,069, entitled INEFFICIENT FAST PCR, filed Apr. 6, 1999 by Kopf-Sill.
- energy is provided to heat fluids, e.g., samples, analytes, buffers and reagents, in desired locations of the substrates in an efficient manner by application of electric current to fluids in microchannels.
- the present invention optionally uses power sources that pass electrical current through a first channel region for heating purposes, as well as for material transport.
- fluid passes through a channel of a desired cross-section (e.g., diameter) to enhance thermal transfer of energy from the current to the fluid.
- the channels can be formed on almost any type of substrate material such as, for example, amorphous materials (e.g., glass, plastic, silicon), composites, multi-layered materials, combinations thereof, and the like.
- POWER power dissipated in fluid
- I electric current passing through fluid
- R electric resistance of fluid
- the above equation provides a relationship between power dissipated (“POWER”) to current (“I”) and resistance (“R”).
- POWER power dissipated
- I current
- R resistance
- a portion of the power goes into kinetic energy of moving the fluid through the channel.
- a selected portion of the power to controllably heat fluid in a channel or selected channel regions.
- a channel region suitable for heating is often narrower or smaller in cross-section than other channel regions in the channel structure, as a smaller cross-section provides higher resistance in the fluid, which increases the temperature of the fluid as electric current passes through.
- the electric current is increased across the length of the channel by increased voltage, which also increases the amount of power dissipated into the fluid to correspondingly increase fluid temperature.
- a power supply applies voltage and/or current in one of many ways.
- a power supply can apply direct current (i.e., DC) or alternating current (AC), which passes through the channel and into a channel region which is smaller in cross-section, thereby heating fluid in the region.
- DC direct current
- AC alternating current
- This current is selectively adjusted in magnitude to complement any voltage or electric field that is applied to move fluid in and out of the region.
- AC current, voltage, and/or frequency can be adjusted, for example, to heat the fluid without substantially moving the fluid.
- a power supply can apply a pulse or impulse of current and/or voltage, which passes through the channel and into a channel region to heat fluid in the region.
- This pulse is selectively adjusted to complement any voltage or electric field that is applied to move fluid in and out of the region.
- Pulse width, shape, and/or intensity can be adjusted, for example, to heat the fluid substantially without moving the fluid or to heat the fluid while moving the fluid.
- the power supply can apply any combination of DC, AC, and pulse, depending upon the application. In practice, direct application of electric current to fluids in the microchannels of the invention results in extremely rapid and easily controlled changes in temperature.
- a controller or computer such as a personal computer monitors the temperature of the fluid in the region of the channel where the fluid is heated.
- the controller or computer receives current and voltage information from, for example, the power supply and identifies or detects temperature of fluid in the region of the channel.
- the controller or computer adjusts voltage and/or current to meet the desired fluid temperature.
- the controller or computer also can be set to be “current controlled” or “voltage controlled” or “power controlled” depending upon the application.
- the region which is heated can be a “coil” which is optionally in a planar arrangement. Transfer of heat from the coil to a reaction channel through a substrate material is used to heat the reaction channel. Alternatively, the coil itself is optionally the reaction channel.
- a voltage is applied between regions of the coil to direct current through the fluid for heating purposes.
- a power supply provides a voltage differential between regions of the coil.
- Current flows between the regions and traverses a plurality of coils or coil loops (which can be planar), which are defined by a substrate. Shape and size of the coils can influence an ability of current to heat the fluid in the coil. As current traverses through the fluid, energy is transferred to the fluid for heating purposes.
- Cooling coils can also be used. As a cooling coil, a fluid traverses from region to region in the coil, which can be placed to permit heat transfer through a substrate from a sample.
- the cooling fluid can be a variety of substances including liquids and gases. As merely an example, the cooling fluid includes aqueous solutions, liquid or gaseous nitrogen, and others. The cooling fluid can be moved between regions using any of the techniques described herein, and others. Further details are found in Chow et al., supra.
- Joule heating in microchannels is an example of how benchtop methods can be dramatically improved in the formats provided herein. PCR takes hours to perform currently, primarily because it takes a long time for conventional heating blocks to oscillate between temperatures. In addition, reagent cost is an obstacle to massive experimentation. Both these parameters are altered by orders of magnitude in the LabChipTM format.
- PCR reaction conditions are controlled as a function of channel geometry.
- Microfabrication methods permit the manufacture of channels that have precise variations in cross sectional area. Since the channel resistance is inversely proportional to the cross sectional area, the temperature varies with the width and depth of the channel for a given flow of current. As fluid moves through a structure of varying cross sectional area, its temperature will change, depending on the dimensions of the channel at any given point. The amount of time it experiences a given temperature will be determined by the velocity of the fluid flow, and the length of channel with those dimensions. This concept is illustrated in FIG. 2. Nucleic acids of typical lengths have a low diffusion coefficient (about 10 ⁇ 7 cm/sec 2 ).
- amplification reactions are performed concurrently in series using biased alternating current to heat the fluid inside the channel and move material through it.
- the time for each step of the reaction is controlled by determining the speed of movement and the length of channel having particular widths. Flow can be reversed to allow a single small channel region to be used for many separate amplifications.
- Sample 215 is in narrow channel region 220 ; in operation, this region is heated to, e.g., 95° C. (hot enough to denature nucleic acids present in sample 215 , but cool enough that thermostable reagents such as Taq DNA polymerase are relatively stable due to the relative size of region 220 and the applied current.
- wide channel region 230 is heated, e.g., to 60° C. (cool enough for binding of primers in sample 225 and initiation of polymerase extension), due to the relative size of region 230 and the applied current.
- intermediate channel region 235 is heated, e.g., to 72° C.
- This process can be concurrently carried out with a plurality of additional channel regions such as narrow region 245 , wide region 250 and intermediate region 255 , with samples 260 , 265 and 270 .
- direct detection of amplified products can be employed.
- differentially labeled competitive probe hybridization is used for single nucleotide discrimination.
- molecular beacons or single nucleotide polymerase extension can be employed.
- Homogeneous detection by fluorescence polarization spectroscopy can also be utilized (fluorescence polarization has been used to distinguish between labeled small molecules free in solution or bound to protein receptors).
- the present invention provides the ability to integrate complex functions such as PCR and nucleic acid separation in a single format, e.g., in a microfluidic device.
- PCR and nucleic acid separations are optionally performed in the same sieving medium, therefore making it possible to perform both functions in a single channel of a microfluidic device.
- FIG. 1 provides a schematic of an example device.
- Device 100 is optionally filled with a sieving medium as described above, e.g., a sieving gel.
- the sieving medium provides a continuous fluid phase throughout the device, such that PCR is optionally carried out by joule heating in one channel, e.g., channel 101 , and product separation in another channel, e.g., channel 103 .
- the entire device is thermocycled to perform PCR. PCR is thereby carried out in the sieving medium.
- PCR reagents and a target nucleic acid are added to the sieving medium if not already incorporated therein, e.g., into channel 101 .
- Cross channel 101 is optionally a PCR channel as described herein and shown in FIG. 2.
- the loaded device is typically placed on a thermocycler (MJ Research) and the temperature is typically cycled to amplify the target nucleic acid.
- the chip is typically placed on a microscope detection station and the product is electrokinetically injected into separation channel 103 .
- voltages are applied at wells 107 and 109 to electrokinetically separate the product nucleic acids.
- An example spectrum showing separated nucleic acid peaks is provided in FIG. 3.
- PCR reaction product is selected for further manipulations such as cloning, sequencing or the like, all of which are optionally performed in the same device (see also, U.S. Ser. No. 60/068,311, entitled “Closed Loop Biochemical Analyzer” by Knapp, filed Dec. 19, 1997 and “Closed Loop Biochemical Analyzers” by Knapp et al. U.S. Ser. No. 09/054,962, filed Apr. 3, 1998).
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Sieving mediums comprising less than about 0.5% polymer, less than about 0.4% polymer, and 0.35% polymer or less are used to perform nucleic acid separations and PCR. The low polymer concentration does not inhibit PCR reactions and is sufficient for performing nucleic acids separations. Microfluidic devices are used to perform nucleic acids separations and PCR reactions in the sieving mediums described.
Description
- Pursuant to 35 U.S.C. § 119(e) and any other applicable statute or rule, the present application claims benefit of and priority to U.S. Ser. No. 60/190,773, entitled “PCR COMPATIBLE NUCLEIC ACID SIEVING MEDIUM,” filed Mar. 20, 2000 by Burd Mehta.
- Manipulating fluidic reagents and assessing the results of reagent interactions are central to chemical and biological science. Manipulations include mixing fluidic reagents, assaying products resulting from such mixtures, separation or purification of products and reagents, and the like. A single experiment may involve hundreds of fluidic manipulations, product separations, recording processes and the like, each of which involve different types of laboratory equipment and conditions.
- One particularly labor intensive biochemical series of laboratory fluidic manipulations is nucleic acid synthesis and analysis. A variety of in vitro amplifications methods for biochemical synthesis of nucleic acids are available, such as the polymerase chain reaction (PCR). See, Mullis et al., (1987) U.S. Pat. No. 4,683,202 and PCR protocols: A Guide to Methods and Applications (Innis et al. eds., Academic Press Inc. San Diego Calif. (1990). PCR methods typically require the use of specialized machinery for performing thermocycling reactions for DNA synthesis followed by the use of special machinery for the electrophoretic analysis of synthesized nucleic acids.
- Various strategies have been used to increase laboratory throughput. For example, microscale devices for high throughput mixing and assaying small fluid volumes have been developed. See, e.g., Parce et al., U.S. Pat. No. 5,942,443, “High Throughput Screening Assay Systems in Microscale Devices,” which provides pioneering technology related to microscale devices. In particular, U.S. Ser. No. 09/093,832 by Burd Mehta et al., “Microfluidic Matrix Localization Apparatus and Methods,” provides methods of performing PCR and nucleic acid separations in the same microfluidic device.
- Improved methods for performing PCR and nucleic acid separations including improved sieving mediums are desirable, particularly those which take advantage of high-throughput, low cost microfluidic systems. The present invention provides these and other features by providing nucleic acid sieving mediums, methods of performing PCR and nucleic acid separations along with high throughput microscale systems and many other features that will be apparent upon complete review of the following disclosure.
- The present invention provides nucleic acid sieving mediums, microfluidic devices, and methods for performing nucleic acid separations and PCR. The sieving mediums provided are compatible with both nucleic acid separations and PCR because they provide baseline nucleic acid separation and do not inhibit PCR.
- In one aspect, a microfluidic device for performing both PCR and nucleic acid separations is provided. The device comprises at least one microscale channel and a sieving medium. The sieving medium is disposed within the at least one microscale channel and comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less.
- Typical polymers include acrylamide, such as linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, and the like. Other polymers include, but are not limited to, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, and the like.
- The devices also optionally comprise one or more proteins, nucleic acids, PCR reaction components, or PCR products disposed within the at least one microfluidic channel. PCR reaction components include, but are not limited to, a polymerase, e.g., a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, and Mg ++.
- In a second aspect, methods of separating polynucleotides are provided. In one embodiment, the method comprises providing two or more polynucleotides and a sieving medium. The polynucleotides typically comprise one or more PCR products, RNA, or DNA. The sieving medium typically comprises a polymer solution as described above. The two or more polynucleotides migrate through the sieving medium, thereby separating the two or more polynucleotides.
- In another embodiment, the sieving medium is introduced into a microfluidic channel and the two or more polynucleotides migrate through the sieving medium in the microfluidic channel. For example, the two or more polynucleotides are optionally separated by electrophoresis in the sieving medium.
- In a third aspect, methods of performing PCR and separating one or more PCR products are provided. The methods comprise mixing one or more PCR reaction component as described above with a sieving medium to provide a PCR sieving medium, wherein the sieving medium comprises a polymer solution as described above. The PCR sieving medium is then thermocycled to produce one or more PCR products, which are separated by flowing in the sieving medium.
- In another embodiment, PCR is performed in a microfluidic device by mixing the PCR reaction components with the sieving medium in a microfluidic channel. The one or more PCR products are separated, e.g., electrophoretically, by flowing the one or more PCR products through the sieving medium in the microfluidic channel.
- In a fourth aspect, nucleic acid sieving mediums are provided. The sieving mediums comprise one or more polynucleotides, such as DNA, RNA, PCR products, or the like, one or more PCR reagents as described above, and a polymer solution as described above.
- FIG. 1 is a schematic drawing of a microfluidic device for performing PCR and nucleic acid separations.
- FIG. 2 is a schematic drawing of a microchannel for joule heating.
- FIG. 3 is a graph providing nucleic acid separation data obtained in a sieving medium comprising 0.35% polymer.
- DNA separations are normally performed in sieving mediums that have a certain concentration of sieving medium to achieve separation of various sizes of DNA fragments. The concentration of polymers used in sieving media typically inhibits the polymerase chain reaction (PCR), thereby preventing the two assays from being carried out in one medium. The present invention provides a mixture compatible with PCR that also serves as a DNA separation medium. The sieving mediums of the present invention comprise lower concentrations of polymer than are normally used to achieve DNA separation. The lower concentrations of polymer do not inhibit PCR and still provide separation of polynucleotides.
- A typical sieving polymer concentration used in DNA separations is about 3%, e.g., 3% acrylamide. This concentration is known to inhibit polymerase chain reactions (PCR). However, lower levels of the same polymer are not inhibitory. The present invention provides a PCR compatible mixture with a low amount of polymer used to suppress electroosmotic flow in the channels of a microfluidic device. The concentration of polymer provided in the present invention is typically less than about 0.5%, more typically less than about 0.4% and preferably about 0.35% or less. Since this is below the usual threshold of sieving, the polymer here was initially used as an agent to eliminate bulk movement of the fluid by acting as a dynamic coating for the channel walls.
- However, the present sieving medium also provided nucleic acid separations in the same low polymer medium in which PCR was performed. While, the exact mechanism of DNA sieving is not known, one advantage of the present medium is to provide a single fluid compatible with PCR and nucleic acid separations. Thus, the present invention provides, with a relatively simple loading or fabrication procedure, multi-step assays, e.g., PCR and subsequent product separation, using the present sieving medium.
- The present invention provides a nucleic acid sieving medium compatible with nucleic acid separations and PCR as well as devices for performing nucleic acid separations and PCR, e.g., devices comprising a sieving medium with a low polymer concentration. Methods of separating nucleic acids and performing PCR using low concentration sieving mediums are also provided.
- I. PCR Compatible Sieving Mediums
- A nucleic acid sieving medium that is compatible with PCR and nucleic acid separations is provided. The sieving medium comprises a low concentration of polymer, which low concentration does not inhibit PCR. Typically DNA is separated in sieving mediums with higher polymer concentrations than those provided herein. However, nucleic acids are optionally separated using the lower polymer concentrations provided herein thereby providing methods for performing nucleic acid separation and PCR in the same medium.
- The sieving medium typically comprises one or more polynucleotides, one or more PCR reagents, and a polymer solution, which polymer solution comprises less than about 0.5% polymer, less than about 0.4% polymer, or about 0.35% polymer or less. The polymer solution is thereby used to provide PCR and nucleic acid separations in the same matrix. In some embodiments, the polymer solution is eliminated and optionally replaced with an electroosmotic flow suppressor.
- The one or more PCR reaction components comprise one or more of: a thermostable polymerase, a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, Mg ++, and the like. The one or more polynucleotides typically comprise DNA, RNA, or PCR products.
- Typical polymer solutions of the invention comprise low concentrations of one or more of the following: acrylamide, agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, hydroxy ethyl cellulose, or the like. Combinations of any of these polymers are also optionally used. Various types of acrylamide are used, including, but not limited to, linear acrylamide, polyacrylamide, polydimethylacrylamide, polydimethylacrylamide/coacrylic acid, or the like.
- A wide variety of alternative sieving mediums are available, and are optionally used in methods of the invention, e.g., at low concentrations to provide a medium compatible with both PCR and nucleic acid separations. For example, a variety of sieving matrixes and the like are available from Supelco, Inc. (Bellefonte, Pa.; see, 1997 Suppleco catalogue). Common matrixes which are useful in the present invention include those generally used in low pressure liquid chromatography, gel electrophoresis and other liquid phase separations; matrix materials designed primarily for non-liquid phase chromatography are also useful in certain contexts, as the materials often retain separatory characteristics when suspended in fluids. For a discussion of electrophoresis see, e.g., Weiss (1995) Ion Chromatography VCH Publishers Inc.; Baker (1995) Capillary Electrophoresis John Wiley and Sons; Kuhn (1993) Capillary Electrophoresis: Principles and Practice Springer Verlag; Righetti (1996) Capillary Electrophoresis in Analytical Biotechnology CRC Press; Hill (1992) Detectors for Capillary Chromatography John Wiley and Sons; Gel Filtration: Principles and Methods (5th Edition) Pharmacia; Gooding and Regnier (1990) HPLC of Biological Macromolecules: Methods and Applications (Chrom. Sci. Series, volume 51) Marcel Dekker and Scott (1995) Techniques and Practices of Chromatography Marcel Dekker, Inc.
- Alternate separation matrix media include, but are not limited to, low pressure liquid chromatography media include, e.g., non-ionic macroreticular and macroporous resins which adsorb and release components based upon hydrophilic or hydrophobic interactions such as Amberchrom resins (highly cross-linked styrene/divinylbenzene copolymers suitable for separation of peptides, proteins, nucleic acids, antibiotics, phytopharmacologicals, and vitamins); the related Amberlite XAD series resins (polyaromatics and acrylic esters) and amberchroms (polyaromatic and polymethacrylates) (manufactured by Rohm and Haas, available through Suppleco); Diaion (polyaromatic or polymethacrylic beads); Dowex (polyaromatics or substituted hydrophilic functionalized polyaromatics) (manufactured by Dow Chemical, available through Suppleco); Duolite (phenol-formaldehyde with methanolic functionality), MCI GEL sephabeads, supelite DAX-8 (acrylic ester) and Supplepak (polyaromatic) (all of the preceding materials are available from Suppleco). For a description of uses for Amberlite and Duolite resins, see, Amberlite/Duolite Anion Exchange Resins (Avaliable from Suppleco, Cat No. T412141). Gel filtration chromatography matrixes are also suitable, including sephacryl, sephadex, sepharose, superdex, superose, toyopearl, agarose, cellulose, dextrans, mixed bead resins, polystyrene, nuclear resins, DEAE cellulose, Benzyl DEA cellulose, TEAE cellulose, and the like (Suppleco).
- Other electrophoresis media include silica gels such as Davisil Silica, E. Merck Silica Gel, Sigma-Aldrich Silica Gel (all available from Suppleco) in addition to a wide range of silica gels available for various purposes as described in the Aldrich catalogue/handbook (Aldrich Chemical Company (Milwaukee, Wis.)). Preferred gel materials include agarose based gels, various forms of acrylamide based gels, Genescan polymers (reagents available from, e.g., Suppleco, SIGMA, Aldrich, SIGMA-Aldrich and many other sources), colloidial solutions such as protein colloids (gelatins) and hydrated starches. Various forms of gels are discussed further below.
- A variety of affinity media for purification and separation of molecular components are also available, including a variety of modified silica gels available from SIGMA, Aldrich and SIGMA-Aldrich, as well as Suppleco, such as acrylic beads, agarose beads, cellulose, sepharose, sepharose CL, toyopearl, or the like chemically linked to an affinity ligand such as a biological molecule. A wide variety of activated matrixes, amino acid resins, avidin and biotin resins, carbohydrate resins, dye resins, glutathione resins, hydrophobic resins, immunochemical resins, lectin resins, nucleotide/coenzyme resins, nucleic acid resins, and specialty resins are available, e.g., from Suppleco, SIGMA, Aldrich or the like. See also, Hermanson et al. (1992) Immobilized Affinity Ligand Techniques Academic Press and optionally used in the channels of the invention.
- Other media commonly used in chromatography are also adaptable to the present invention, including activated aluminas, carbopacks, carbosieves, carbowaxes, chromosils, DEGS, Dexsil, Durapak, Molecular Sieve, OV phases, pourous silica, chromosorb series packs, HayeSep series, Porapak series, SE-30, Silica Gel, SP-1000, SP-1200, SP-2100, SP-2250, SP-2300, SP2401, Tenax, TCEP, supelcosil LC-18-S and LC-18-T, Methacrylate/DVBm, polyvinylalcohols, napthylureas, non-polar methyl silicone, methylpolysiloxane, poly (ethylene glycol) biscyanopropyl polysiloxane and the like.
- Other types of separation matrices are also optionally used and discussed in U.S. patent application Ser. No. 09/093,832 filed Jun., 8, 1998, entitled “Microfluidic Matrix Localizations Apparatus and Methods,” by Mehta and Kopf-Sill. For a review of chromatography techniques and media, see, e.g., Affinity Chromatography—A Practical Approach, Dean et al., (Eds.) IRL Press, Oxford (1985); and, Chromatographic Methods, 5 th Edition, Braithwaite et al., (1996).
- Many of the materials used to provide the sieving mediums of the invention are supplied in a liquid or fluidic phase and then polymerized to provide a sieving matrix. In one embodiment, the fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer). The fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired. Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure.
- A wide variety of free-radical polymerizable monomers photopolymerize to form gels, or can be made photopolymerizeable by the addition of, e.g., energy transfer dyes. For example, free-radical polymerizable monomers can be selected from acrylate, methacrylate and vinyl ester functionalized materials. They can be monomers and/or oligomers such as (meth)acrylates (meth)acrylamides, acrylamides, vinyl pyrrolidone and azalactones. Such monomers include mono-, di-, or poly-acrylates and methacrylates such as methyl acrylate, methyl methacrylate, ethyl acrylate, isopropyl methacrylate, isooctyl acrylate, isobornyl acrylate, isobornyl methacrylate, acrylic acid, n-hexyl acrylate, stearyl acrylate, allyl acrylate, glycerol diacrylate, glycerol triacrylate, ethylene glycol diacrylate, diethyleneglycol diacrylate, triethyleneglycol dimethacrylate, 1,6-hexanediol diacrylate, 1,3-propanediol diacrylate, 1,3-propanediol dimethacrylate, trimethanol triacrylate, 1,2,4-butanetriol trimethylacrylate, 1,4-cyclohexanediol diacrylate, pentaerythritol triacrylate, pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, sorbitol hexacrylate, bis[1-(2-acryloxy)]-p-ethoxyphenyl-dimethylmethane, bis[1-(3-acryloxy-2-hydroxy)]-propoxyphenyl dimethylmethane, tris-hydroxyethyl isocyanurate trimethacrylate; the bis-acrylates and bis-methacrylates of polyethylene glycols of molecular weight 200-500, copolymerizable mixtures of acrylated monomers, acrylated oligomers, PEG diacrylates, etc. Strongly polar monomers such as acrylic acid, acrylamide, itaconic acid, hydroxyalkyl acrylates, or substituted acrylamides or moderately polar monomers such as N-vinyl-2-pyrrolidone, N-vinyl caprolactam, and acrylonitrile are also useful.
- Proteins such as gelatin, collagen, elastin, zein, and albumin, whether produced from natural or recombinant sources, which are made by free-radical polymerization by the addition of carbon-carbon double or triple bond-containing moieties, including acrylate, diacrylate, methacrylate, ethacrylate, 2-phenyl acrylate, 2-chloro acrylate, 2-bromo acrylate, itaconate, oliogoacrylate, dimethacrylate, oligomethacrylate, acrylamide, methacrylamide, styrene groups, and other biologically acceptable photopolymerizable groups, can also be used, e.g., in low concentration, to form sieving matrixes.
- Dye-sensitized polymerization is well known in the chemical literature. For example, light from an argon ion laser (514 nm), in the presence of an xanthin dye and an electron donor, such as triethanolamine, to catalyze initiation, serves to induce a free radical polymerization of acrylic groups in a reaction mixture (Neckers, et al., (1989) Polym. Materials Sci. Eng., 60:15; Fouassier, et al., (1991) Makromol. Chem., 192:245-260). After absorbing laser light, the dye is excited to a triplet state. The triplet state reacts with a tertiary amine such as the triethanolamine, producing a free radical which initiates a polymerization reaction. Polymerization is extremely rapid and is dependent on the functionality of the composition, its concentration, light intensity, and the concentration of dye and, e.g., amine.
- Dyes are also optionally used which absorb light having a frequency between 320 nm and 900 nm, form free radicals, are water soluble, etc. There are a large number of photosensitive dyes that are optionally used to optically initiate polymerization, such as ethyl eosin, eosin Y, fluorescein, 2,2-dimethoxy-2-phenyl acetophenone, 2-methoxy,2-phenylacetophenone, camphorquinone, rose bengal, methylene blue, erythrosin, phloxime, thionine, riboflavin, methylene green, acridine orange, xanthine dye, and thioxanthine dyes.
- Cocatalysts useful with photoinitiating dyes are typically nitrogen based compounds capable of stimulating a free radical reaction. Primary, secondary, tertiary or quaternary amines are suitable cocatalysts, as are nitrogen atoms containing electron-rich molecules. Cocatalysts include triethanolamine, triethylamine, ethanolamine, N-methyl diethanolamine, N,N-dimethyl benzylamine, dibenzyl amine, N-benzyl ethanolamine, N-isopropyl benzylamine, tetramethyl ethylenediamine, potassium persulfate, tetramethyl ethylenediamine, lysine, ornithine, histidine and arginine. Examples of the dye/photoinitiator system include ethyl eosin with an amine, eosin Y with an amine, 2,2-dimethoxy-2-phenoxyacetophenone, 2-methoxy-2-phenoxyacetophenone, camphorquinone with an amine, and rose bengal with an amine.
- In some cases, dye may absorb light and initiate polymerization, without any additional initiator such as an amine. In these cases, only the dye and a monomer need be present to initiate polymerization upon exposure to light. The generation of free radicals is terminated when the laser light is removed. Some photoinitiators, such as 2,2-dimethoxy-2-phenylacetophenone, do not require any auxiliary amine to induce photopolymerization; in these cases, the presence of dye, monomer, and an appropriate wavelength of light is sufficient for photopolymerization.
- Preferred light sources include various lamps and lasers such as those which have a wavelength of about 320-800 nm. This light can be provided by any appropriate source able to generate the desired radiation, such as a mercury lamp, longwave UV lamp, He-Ne laser, an argon ion laser, etc. In a preferred embodiment, a UV source is used to polymerize a UV photopolymerizeable gel. Similarly, the light source used is typically selected based upon the chemistry which is to be affected by the source.
- Similarly, a variety of gels or polymers are selectively polymerized by exposure to heat. As described herein, selective heat control using applied current is easily performed in the microfluidic apparatus of the invention, providing for simplified control of gel polymerization through thermal processes. Examples include initiation by thermal initiators, which form free radicals at moderate temperatures, such as benzoyl peroxide, with or without triethanolamine, potassium persulfate, with or without tetramethylethylenediamine, and ammonium persulfate with sodium bisulfite.
- In another embodiment, the fluid is polymerized by selectively exposing it to an activator or cross-linker. For example, where the fluid is polyacrylamide, the activator/cross linker can be TEMED and/or APS.
- The above polymers, e.g., in solution format, gel format, or the like, and typically polymerized as described above, are typically used in microfluidic devices to provide devices useful for both PCR and separation of nucleic acids.
- II. Separating nucleic acids in a polymer sieving medium
- A mixture of polynucleotides, e.g., DNA or RNA molecules or fragments thereof, PCR products, sequencing reaction products, and the like, are separated by size and/or charge in a sieving medium, e.g., a sieving medium as described above. For example, the separation is typically an electrophoretic separation. The separated products are detected, often as they pass a detector (nucleic acids are typically labeled with radioactive nucleotides or fluorophores; accordingly appropriate detectors include spectrophotometers, fluorescent detectors, microscopes (e.g., for fluorescent microscopy) and scintillation counting devices). If the separated components are the products of a sequencing reaction, e.g., a chain termination method of sequencing, detection of size separated products is used to compile sequence information for the region being sequenced.
- Typically electrophoretic separation is used to separate the mixture of components in the sample. Electrophoretic separation is the separation of substances achieved by applying an electric field to samples in a solution or gel, e.g., a polymer solution. In its simplest form, it depends on the different velocities with which the substances or components move in the field. The velocities depend, e.g., on the charge and size of the substances.
- In a preferred embodiment, the polynucleotides are separated in a microscale separation channel or capillary. The separation channels or regions typically comprise a separation matrix, e.g., a polymerized sieving medium as discussed above. When the sample is flowed through the separation matrix, the components are separated, e.g., based on physical or chemical properties, such as molecular weight or charge. In the present invention, the sieving medium optionally comprises a gel or solution. In the present invention, the concentration of the polymer in the separation gel or solution is less than about 0.5%. Typically the concentration of the sieving medium is less than about 0.4% and more typically about 0.35% or less. In other embodiments, the polymer concentration can be greater than 0.5%, e.g., 0.55%, 0.6% or higher. See e.g., U.S. Ser. No. 09/093,832 by Burd Mehta et al.
- Preferably, the channel, such as
channel 103 in FIG. 1, is a polyacrylamide gel filled channel or a polydimethylacrylamide/co-acrylic acid polymer filled channel on which the mixture of components is electrophoretically separated based on charge/mass ratio or molecular weight. Polyacrylamide used as a separation matrix in a microfluidic channel is optionally cross-linked or non-cross-linked. Preferably it is linear polyacrylamide, i.e., polydimethylacrylamide, polydimethylacrylamide/co-acrylic acid, or the like. Other polymers include cellulose, agarose, Genescan polymers, and the like. - For a review of electrophoretic separation techniques and polyacrylamide gels, see, e.g., The Encyclopedia of Molecular Biology, Kendrew (ed.) (1994); and, Gel Electrophoresis of Proteins: A Practical Approach, 2 nd edition Hames and Rickwood (Eds.) IRL Press, Oxford England, (1990).
- A detector is optionally positioned so that it detects the polynucleotides, e.g., polynucleotides that are stained in the gel with a fluorescent nucleic acid stain. If the components are detected as they exit the separation region, the components are optionally identified by their retention times. The retention time of the oligonucleotides as they are electrophoresed through the sieving medium is used, e.g., in combination with markers to measure the molecular weight of and identify the polynucleotides.
- FIG. 3 demonstrates baseline separation of polynucleotides achieved using the low polymer concentration sieving mediums of the present invention, e.g., a sieving medium comprising 0.35% polymer.
- III. Performing PCR in a sieving medium
- One aspect of the present invention is the surprising discovery that PCR can be performed in the same sieving matrix used to separate nucleic acids. For example, PCR is optionally performed in the presence of a low polymer sieving matrix, and the products of the PCR reaction are separable in the same sieving matrix, e.g., in a microfluidic channel.
- Accordingly, in one aspect, the invention provides new methods of performing PCR. In the methods, components of a PCR reaction mixture (i.e., the molecules which participate in a PCR reaction, such as PCR extension primers, nucleotide triphosphates, thermostable enzymes, ions and buffer components such as Mg ++, template DNAs, etc.) are mixed with a sieving medium comprising less than about 0.5% polymer to provide a PCR sieving medium. Typically, the sieving medium comprises less than about 0.4% polymer. In a preferred embodiment, the sieving medium comprises about 0.35% polymer or less. In other embodiments, the sieving medium can comprise more than 0.5% polymer. The resulting mixture, e.g., the PCR sieving medium, is then repetitively thermocycled as described below to produce one or more PCR products, which are separated, e.g., electrophoretically, in the same sieving medium. Sieving mediums of use in performing PCR, e.g., with nucleic acid separation of the products, are described above.
- Bench scale in vitro amplification techniques suitable for amplifying sequences to provide a nucleic acid e.g., as a diagnostic indicator for the presence of the sequence, or for subsequent analysis, sequencing or subcloning are known.
- In brief, the most common form of in vitro amplification, i.e., PCR amplification, generally involves the use of one strand of the target nucleic acid sequence, e.g., the sequence to be amplified, as a template for producing a large number of complements to that sequence. Generally, two primer sequences complementary to different ends of a segment of the complementary strands of the target sequence hybridize with their respective strands of the target sequence, and in the presence of polymerase enzymes and nucleoside triphosphates, the primers are extended along the target sequence through the action of the polymerase enzyme (in asymmetric PCR protocols, a single primer is used). The extensions are melted from the target sequence by raising the temperature of the reaction mixture, and the process is repeated, this time with the additional copies of the target sequence synthesized in the preceding steps. PCR amplification typically involves repeated cycles of denaturation, hybridization and extension reactions to produce sufficient amounts of the target nucleic acid, all of which are carried out at different temperatures. Typically, melting of the strands, or heat denaturation, involves temperatures ranging from about 90° C. to 100° C. for times ranging from seconds to minutes. The temperature is then cycled down, e.g., to between about 40° C. and 65° C. for annealing of primers, and then cycled up to between about 70° C. and 85° C. for extension of the primers along the target strand. This process if referred to herein as “thermocycling.”
- Examples of techniques sufficient to direct persons of skill through in vitro amplification methods at benchtop scales, including the polymerase chain reaction (PCR) the ligase chain reaction (LCR), Qβ-replicase amplification and other RNA polymerase mediated techniques (e.g., NASBA) are found in Berger, Sambrook, and Ausubel, as well as Mullis et al., (1987) U.S. Pat. No. 4,683,202; PCR Protocols A Guide to Methods and Applications (Innis et al. eds) Academic Press Inc. San Diego, Calif. (1990) (Innis); Arnheim & Levinson (Oct. 1, 1990) C&EN 36-47; The Journal Of NIH Research (1991) 3, 81-94; (Kwoh et al. (1989) Proc. Natl. Acad. Sci. USA 86, 1173; Guatelli et al. (1990) Proc. Natl. Acad. Sci. USA 87, 1874; Lomell et al. (1989) J. Clin. Chem 35, 1826; Landegren et al., (1988) Science 241, 1077-1080; Van Brunt (1990) Biotechnology 8, 291-294; Wu and Wallace, (1989) Gene 4, 560; Barringer et al. (1990) Gene 89, 117, and Sooknanan and Malek (1995) Biotechnology 13: 563-564. Improved methods of cloning in vitro amplified nucleic acids are described in Wallace et al., U.S. Pat. No. 5,426,039. Improved methods of amplifying large nucleic acids by PCR are summarized in Cheng et al. (1994) Nature 369: 684-685 and the references therein, in which PCR amplicons of up to 40 kb are generated. One of skill will appreciate that essentially any RNA can be converted into a double stranded DNA suitable for restriction digestion, PCR expansion and sequencing using reverse transcriptase and a polymerase. See, Ausbel, Sambrook and Berger, all supra.
- In the present invention, the PCR reactants are mixed with a sieving medium comprising a low polymer concentration, e.g., 0.5% or less. The products are then directly separated, e.g., in a capillary, using the same sieving medium.
- In preferred embodiments, the components of the PCR reaction mixture, e.g., a polymerase, nucleotides, and the like, are mixed with a sieving medium, e.g., with a low polymer concentration, in a microfluidic channel, e.g., a channel on a LABCHIP™, as described in more detail below. The apparatus optionally includes one or more additional channels crossing the microfluidic channel and optionally includes fluid (or joule heating) means such as an electrokinetic controller for thermocycling and fluid direction systems, e.g., electrokinetic controllers and/or pressure sources such as vacuum sources, for flowing materials and reagents through the channels. The PCR products are typically electrophoresed through the channels in the same sieving medium used to achieve product separation. Detection regions in the channels and corresponding detectors are also used, e.g., to detect the separated products.
- IV. Microfluidic devices comprising a PCR compatible nucleic acid sieving medium
- The sieving medium of the invention is typically used in a microfluidic device and the separation and PCR methods described above are preferably performed in a microfluidic device. The sieving medium is typically polymerized in a microscale channel of a microfluidic device, e.g., after the PCR reaction. Alternatively, dynamic sieving mediums, such as Genescan polymers, are used that do not require polymerization in the channel. PCR and separation of the products are both optionally performed in a sieving medium of the present invention in the channels of a microfluidic device.
- A variety of microfluidic devices are optionally adapted for use in the present invention, e.g., by designing and configuring the channels as discussed below. These devices are described in various PCT applications and issued U.S. Patents by the inventors and their coworkers, including U.S. Pat. Nos. 5,699,157 (J. Wallace Parce) issued Dec. 16, 1997, 5,779,868 (J. Wallace Parce et al.) issued Jul. 14, 1998, 5,800,690 (Calvin Y. H. Chow et al.) issued Sep. 1, 1998, 5,842,787 (Anne R. Kopf-Sill et al.) issued Dec. 1, 1998, 5,852,495 (J. Wallace Parce) issued Dec. 22, 1998, 5,869,004 (J. Wallace Parce et al.) issued Feb. 9, 1999, 5,876,675 (Colin B. Kennedy) issued Mar. 2, 1999, 5,880,071 (J. Wallace Parce et al.) issued Mar. 9, 1999, 5,882,465 (Richard J. McReynolds) issued Mar. 16, 1999, 5,885,470 (J. Wallace Parce et al.) issued Mar. 23, 1999, 5,942,443 (J. Wallace Parce et al.) issued Aug. 24, 1999, 5,948,227 (Robert S. Dubrow) issued Sep. 7, 1999, 5,955,028 (Calvin Y. H. Chow) issued Sep. 21, 1999, 5,957,579 (Anne R. Kopf-Sill et al.) issued Sep. 28, 1999, 5,958,203 (J. Wallace Parce et al.) issued Sep. 28, 1999, 5,958,694 (Theo T. Nikiforov) issued Sep. 28, 1999, and 5,959,291 (Morten J. Jensen) issued Sep. 28, 1999; and published PCT applications, such as, WO 98/00231, WO 98/00705, WO 98/00707, WO 98/02728, WO 98/05424, WO 98/22811, WO 98/45481, WO 98/45929, WO 98/46438, and WO 98/49548, WO 98/55852, WO 98/56505, WO 98/56956, WO 99/00649, WO 99/10735, WO 99/12016, WO 99/16162, WO 99/19056, WO 99/19516, WO 99/29497, WO 99/31495, WO 99/34205, WO 99/43432, and WO 99/44217.
- In particular, the use of sieving mediums in PCR and nucleic acid separations in microfluidic devices is described in U.S. Ser. No. 09/093,832, by Burd Mehta, filed Jun. 8, 1998. In addition, various other elements are optionally included in the device, such as particle sets, separation gels, antibodies, enzymes, substrates, and the like. These optional elements are used in performing various assays, such as nucleic acid sequencing. For example, the use of particle sets in nucleic acid sequencing is described, e.g., in WO 00/50172, published Aug. 31, 2000, entitled “Manipulation of Microparticles In Microfluidic Systems,” by Burd Mehta et al.
- Complete integrated systems with fluid handling, signal detection, sample storage and sample accessing are also available. For example WO 98/00231 (supra) provides pioneering technology for the integration of microfluidics and sample selection and manipulation.
- One aspect of the invention is the placement of the sieving medium in selected channels or channel regions of a microfluidic substrate. These materials (or precursors of the materials, e.g., monomers polymerized in the device as discussed above) are loaded into microfluidic components by electrokinesis, by pressurized pumping, by centrifugal force, or capillary flow. The present invention provides methods of DNA separation and PCR that are both compatible with the sieving mediums of the invention. Therefore, the sieving medium is typically loaded throughout the entire device. However if other assays are steps are desired, e.g., DNA sequencing reactions, certain channels are optionally filled with reagents for the desired assay or left empty.
- Several methods of providing fluidic regions in selected regions of a channel, or selected channels are provided. In a first aspect, multiple microfluidic regions are filled with a sieving medium, e.g., in an unpolymerized solution that, upon polymerization, forms a sieving matrix. Elements of the microfluidic device such as microfluidic channels are filled with the sieving medium by forcing the fluid into the channel under pressure, or by moving the fluid into the channel electrokinetically. In one embodiment, the first fluid polymerizes upon exposure to light (i.e., the fluid comprises a “photopolymerizable” polymer). The fluid is then selectively exposed to light (e.g., using photomasking techniques) in those regions where a polymerized gel is desired. Unpolymerized fluid is then optionally washed out of the unselected regions of the microfluidic device, or into a waste reservoir using electrokinetic flow or pressure.
- For either the thermal or photopolymerization methods herein, monomer is pumped, e.g., in aqueous buffer, into a channel or channel region using electroosmotic flow, or using a pressure gradient. After selective exposure to light or heat, as appropriate, unpolymerized materials are removed, typically using electroosmotic flow, but optionally using a pressure gradient, from regions where monomer material is undesirable.
- In another embodiment, a sieving matrix is deposited throughout a channel or channels of a microfluidic device in a form which is subject to electroosmosis (i.e., the matrix moves electrokinetically in the channel).
- In an additional embodiment, a sieving medium is loaded into multiple channels of a microfluidic device, e.g., under pressure, and polymerized in place. Selective components which solubilize the polymerized gel are then loaded (e.g., electrokinetically or under pressure) into channel regions where polymerized product is not desired, i.e., channels in which other assays are to be performed. The selected components dissolve the polymerized gel. Example of solubilization compounds include acids, bases and other chemicals. In one preferred embodiment, at least two compounds are used to dissolve polymerized products, where both products need to be present to dissolve the polymer. This provides for fine control of dissolution, e.g., where each chemical is under separate electrokinetic control. An example of such a chemical pair is DTT(N,N′-bis(acrylol)cystamine or (1,2-dihydroxyethylene-bis-acrylamide) [DHEBA] and sodium periodiate or calcium alginate+EDTA or TCEP-HCL and N,N′-bis(acryloyl)cystamine. A variety of such materials are known.
- The sieving medium of the invention is particularly useful for performing experimental or diagnostic procedures which combine nucleic acid amplification and product separatory aspects. For example, PCR is performed in a microfluidic channel comprising a sieving medium as described herein, followed by separation in the same sieving medium, e.g., in the same or in a different channel region.
- In one aspect, PCR or other thermal reaction reagents (e.g., LCR reagents) such as thermostable polymerase, DNA template, primers, nucleotides and buffers are mixed, e.g., with a sieving medium, in a microchannel or chamber, with the entire microfluidic substrate (e.g., a LABCHIP™ from Caliper Technologies) being subject to repeated cycles of heating and cooling, e.g., on a thermocycler or by switching between a hot plate and a heat sink.
- In a second more preferred embodiment, variations in channel thickness and/or voltage are used selectively to heat selected regions of a channel which contain a PCR reaction. PCR amplification is particularly well suited to this use in the apparatus, methods and systems of the invention. Thermocycling amplification methods, including PCR and LCR, are conveniently performed in microscale devices, making iterative fluidic operations involving PCR well suited to use in methods and devices of the present invention (see also, U.S. Pat. Nos. 5,498,392 and 5,587,128 to Willingham et al.). Accordingly, in one preferred embodiment, generation of amplicons such as sequencing templates using PCR, or direct sequencing of nucleic acids by PCR (e.g., using nuclease digestion as described supra) is performed with the integrated systems and devices of the invention.
- Thermocycling in microscale devices, including thermocycling by joule heating is described in WO 99/12016, entitled “ELECTRICAL CURRENT FOR CONTROLLING FLUID PARAMETERS IN MICROCHANNELS” published Mar. 11, 1999 by Calvin Chow, Anne R. Kopf-Sill and J. Wallace Parce; in 08/977,528, filed Nov. 25, 1997; in WO 98/45481, entitled “CLOSED-LOOP BIOCHEMICAL ANALYZERS,” published Oct. 15, 1998; and in 09/287,069, entitled INEFFICIENT FAST PCR, filed Apr. 6, 1999 by Kopf-Sill. In brief, energy is provided to heat fluids, e.g., samples, analytes, buffers and reagents, in desired locations of the substrates in an efficient manner by application of electric current to fluids in microchannels. Thus, the present invention optionally uses power sources that pass electrical current through a first channel region for heating purposes, as well as for material transport. In exemplary embodiments, fluid passes through a channel of a desired cross-section (e.g., diameter) to enhance thermal transfer of energy from the current to the fluid. The channels can be formed on almost any type of substrate material such as, for example, amorphous materials (e.g., glass, plastic, silicon), composites, multi-layered materials, combinations thereof, and the like.
- In general, electric current passing through the fluid in a channel produces heat by dissipating energy through the electrical resistance of the fluid. Power dissipates as the current passes through the fluid and goes into the fluid as energy as a function of time to heat the fluid. The following mathematical expression generally describes a relationship between power, electrical current, and fluid resistance:
- POWER=I2R
- where
- POWER=power dissipated in fluid;
- I=electric current passing through fluid; and
- R=electric resistance of fluid.
- The above equation provides a relationship between power dissipated (“POWER”) to current (“I”) and resistance (“R”). In some of the embodiments, which are directed toward moving fluid in channels, e.g., to provide mixing, electrophoretic separation, or the like, a portion of the power goes into kinetic energy of moving the fluid through the channel. However, it is also possible to use a selected portion of the power to controllably heat fluid in a channel or selected channel regions. A channel region suitable for heating is often narrower or smaller in cross-section than other channel regions in the channel structure, as a smaller cross-section provides higher resistance in the fluid, which increases the temperature of the fluid as electric current passes through. Alternatively, the electric current is increased across the length of the channel by increased voltage, which also increases the amount of power dissipated into the fluid to correspondingly increase fluid temperature.
- To selectively control the temperature of fluid at a region of the channel, a power supply applies voltage and/or current in one of many ways. For instance, a power supply can apply direct current (i.e., DC) or alternating current (AC), which passes through the channel and into a channel region which is smaller in cross-section, thereby heating fluid in the region. This current is selectively adjusted in magnitude to complement any voltage or electric field that is applied to move fluid in and out of the region. AC current, voltage, and/or frequency can be adjusted, for example, to heat the fluid without substantially moving the fluid. Alternatively, a power supply can apply a pulse or impulse of current and/or voltage, which passes through the channel and into a channel region to heat fluid in the region. This pulse is selectively adjusted to complement any voltage or electric field that is applied to move fluid in and out of the region. Pulse width, shape, and/or intensity can be adjusted, for example, to heat the fluid substantially without moving the fluid or to heat the fluid while moving the fluid. Still further, the power supply can apply any combination of DC, AC, and pulse, depending upon the application. In practice, direct application of electric current to fluids in the microchannels of the invention results in extremely rapid and easily controlled changes in temperature.
- A controller or computer such as a personal computer monitors the temperature of the fluid in the region of the channel where the fluid is heated. The controller or computer receives current and voltage information from, for example, the power supply and identifies or detects temperature of fluid in the region of the channel. Depending upon the desired temperature of fluid in the region, the controller or computer adjusts voltage and/or current to meet the desired fluid temperature. The controller or computer also can be set to be “current controlled” or “voltage controlled” or “power controlled” depending upon the application.
- The region which is heated can be a “coil” which is optionally in a planar arrangement. Transfer of heat from the coil to a reaction channel through a substrate material is used to heat the reaction channel. Alternatively, the coil itself is optionally the reaction channel.
- A voltage is applied between regions of the coil to direct current through the fluid for heating purposes. In particular, a power supply provides a voltage differential between regions of the coil. Current flows between the regions and traverses a plurality of coils or coil loops (which can be planar), which are defined by a substrate. Shape and size of the coils can influence an ability of current to heat the fluid in the coil. As current traverses through the fluid, energy is transferred to the fluid for heating purposes. Cooling coils can also be used. As a cooling coil, a fluid traverses from region to region in the coil, which can be placed to permit heat transfer through a substrate from a sample. The cooling fluid can be a variety of substances including liquids and gases. As merely an example, the cooling fluid includes aqueous solutions, liquid or gaseous nitrogen, and others. The cooling fluid can be moved between regions using any of the techniques described herein, and others. Further details are found in Chow et al., supra.
- The introduction of electrical current into fluid causes heat (this procedure is referred to as “Joule heating”). In the examples of fluid movement herein where thermal effects are not desired, the heating effect is minimal because, at the small currents employed, heat is rapidly dissipated into the chip itself. By substantially increasing the current across the channel, rapid temperature changes are induced that can be monitored by conductivity. At the same time, the fluid can be kept static in the channel by using alternating instead of direct current. Because nanoliter volumes of fluid have tiny thermal mass, transitions between temperatures can be extremely short. Oscillations between any two temperatures above 0° C. and below 100° C. in 100 milliseconds have been performed.
- Joule heating in microchannels is an example of how benchtop methods can be dramatically improved in the formats provided herein. PCR takes hours to perform currently, primarily because it takes a long time for conventional heating blocks to oscillate between temperatures. In addition, reagent cost is an obstacle to massive experimentation. Both these parameters are altered by orders of magnitude in the LabChip™ format.
- In one aspect, PCR reaction conditions are controlled as a function of channel geometry. Microfabrication methods permit the manufacture of channels that have precise variations in cross sectional area. Since the channel resistance is inversely proportional to the cross sectional area, the temperature varies with the width and depth of the channel for a given flow of current. As fluid moves through a structure of varying cross sectional area, its temperature will change, depending on the dimensions of the channel at any given point. The amount of time it experiences a given temperature will be determined by the velocity of the fluid flow, and the length of channel with those dimensions. This concept is illustrated in FIG. 2. Nucleic acids of typical lengths have a low diffusion coefficient (about 10 −7 cm/sec2). Thus over the time frame necessary to affect amplification, DNA will only diffuse a few hundred microns. In a given channel, reactions of a few nanoliters will occupy a few millimeters. Thus in devices of convenient length (a few centimeters), many PCR reactions can be performed concurrently yielding new amplification products every few seconds per channel. In parallel formats, hundreds of separate reactions can be performed simultaneously. Because of its simplicity, throughput, and convenience, this amplification unit is a preferred feature of many assays herein.
- In FIG. 2, amplification reactions are performed concurrently in series using biased alternating current to heat the fluid inside the channel and move material through it. The time for each step of the reaction is controlled by determining the speed of movement and the length of channel having particular widths. Flow can be reversed to allow a single small channel region to be used for many separate amplifications.
- As depicted, several samples are run simultaneously in
channel 210.Sample 215 is innarrow channel region 220; in operation, this region is heated to, e.g., 95° C. (hot enough to denature nucleic acids present insample 215, but cool enough that thermostable reagents such as Taq DNA polymerase are relatively stable due to the relative size ofregion 220 and the applied current. Concurrently,wide channel region 230 is heated, e.g., to 60° C. (cool enough for binding of primers insample 225 and initiation of polymerase extension), due to the relative size ofregion 230 and the applied current. Concurrently,intermediate channel region 235 is heated, e.g., to 72° C. (hot enough to prevent unwanted non-specific primer-target nucleic acid interactions insample 240 and cool enough to permit continued polymerase extension), due to the relative size ofregion 235 and the applied current. This process can be concurrently carried out with a plurality of additional channel regions such asnarrow region 245,wide region 250 andintermediate region 255, with 260, 265 and 270.samples - Where possible, direct detection of amplified products can be employed. For example, differentially labeled competitive probe hybridization is used for single nucleotide discrimination. Alternatively, molecular beacons or single nucleotide polymerase extension can be employed. Homogeneous detection by fluorescence polarization spectroscopy can also be utilized (fluorescence polarization has been used to distinguish between labeled small molecules free in solution or bound to protein receptors).
- The present invention provides the ability to integrate complex functions such as PCR and nucleic acid separation in a single format, e.g., in a microfluidic device. PCR and nucleic acid separations are optionally performed in the same sieving medium, therefore making it possible to perform both functions in a single channel of a microfluidic device.
- For example, a Caliper LabChip™ is optionally used to load DNA template, run the PCR reaction, and then size the resulting PCR product by gel separation. FIG. 1 provides a schematic of an example device. Device 100 is optionally filled with a sieving medium as described above, e.g., a sieving gel. The sieving medium provides a continuous fluid phase throughout the device, such that PCR is optionally carried out by joule heating in one channel, e.g.,
channel 101, and product separation in another channel, e.g.,channel 103. Alternatively, the entire device is thermocycled to perform PCR. PCR is thereby carried out in the sieving medium. PCR reagents and a target nucleic acid are added to the sieving medium if not already incorporated therein, e.g., intochannel 101.Cross channel 101 is optionally a PCR channel as described herein and shown in FIG. 2. The loaded device is typically placed on a thermocycler (MJ Research) and the temperature is typically cycled to amplify the target nucleic acid. At the end of the cycling procedure, the chip is typically placed on a microscope detection station and the product is electrokinetically injected intoseparation channel 103. For example, voltages are applied at 107 and 109 to electrokinetically separate the product nucleic acids. An example spectrum showing separated nucleic acid peaks is provided in FIG. 3.wells - It will be appreciated that separations chips comprising a single sieving matrix are produced as described above. However, additional fluidic phases are optionally placed in additional channels or channel regions in fluid communication with a channel region comprising the PCR sieving mixture for electrophoretic or electroosmotic movement of the PCR components or products in the chips. For example, in some aspects a PCR reaction product is selected for further manipulations such as cloning, sequencing or the like, all of which are optionally performed in the same device (see also, U.S. Ser. No. 60/068,311, entitled “Closed Loop Biochemical Analyzer” by Knapp, filed Dec. 19, 1997 and “Closed Loop Biochemical Analyzers” by Knapp et al. U.S. Ser. No. 09/054,962, filed Apr. 3, 1998).
- While the foregoing invention has been described in some detail for purposes of clarity and understanding, it will be clear to one skilled in the art from a reading of this disclosure that various changes in form and detail can be made without departing from the true scope of the invention. For example, all the techniques and apparatus described above may be used in various combinations. All publications, patents, patent applications, or other documents cited in this application are incorporated by reference in their entirety for all purposes to the same extent as if each individual publication, patent, patent application, or other document were individually indicated to be incorporated by reference for all purposes.
Claims (35)
1. A microfluidic device for performing PCR and nucleic acid separations, the device comprising at least one microscale channel and a sieving medium, which sieving medium is disposed within the at least one microscale channel and comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer.
2. The microfluidic device of claim 1 , wherein the polymer solution comprises less than about 0.4% polymer.
3. The microfluidic device of claim 1 , wherein the polymer solution comprises about 0.35% polymer or less.
4. The microfluidic device of claim 1 , wherein the polymer solution comprises acrylamide.
5. The microfluidic device of claim 4 , wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
6. The microfluidic device of claim 1 , wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
7. The microfluidic device of claim 1 , further comprising one or more proteins, nucleic acids, PCR reaction components, or PCR products disposed within the at least one microfluidic channel.
8. The microfluidic device of claim 7 , wherein the PCR reaction components comprise one or more of: a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, or Mg++.
9. A method of separating polynucleotides, the method comprising:
(i) providing two or more polynucleotides;
(ii) providing a sieving medium, which sieving medium comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer;
(iii) allowing the two or more polynucleotides to migrate through the sieving medium, thereby separating the two or more polynucleotides.
10. The method of claim 9 , wherein the polynucleotides comprise one or more PCR products, RNA, or DNA.
11. The method of claim 9 , wherein the polymer solution comprises less than about 0.4% polymer.
12. The method of claim 9 , wherein the polymer solution comprises about 0.35% polymer or less.
13. The method of claim 9 , wherein the polymer solution comprises acrylamide.
14. The method of claim 13 , wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
15. The method of claim 9 , wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
16. The method of claim 9 , further comprising introducing the sieving medium into a microfluidic channel and allowing the two or more polynucleotides to migrate through the sieving medium in the microfluidic channel.
17. The method of claim 9 , wherein the separating comprises electrophoretically separating the two or more polynucleotides.
18. A method of performing PCR and separating one or more PCR products, the method comprising:
(i) mixing one or more PCR reaction components with a sieving medium to provide a PCR sieving medium, wherein the sieving medium comprises a polymer solution, which polymer solution comprises less than about 0.5% polymer; and
(ii) thermocycling the PCR sieving medium to produce one or more PCR products; and,
(iii) separating the one or more PCR products by flowing the one or more PCR products through the sieving medium.
19. The method of claim 18 , wherein the polymer solution comprises less than about 0.4% polymer.
20. The method of claim 19 , wherein the polymer solution comprises about 0.35% polymer or less.
21. The method of claim 18 , wherein the polymer solution comprises acrylamide.
22. The method of claim 21 , wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
23. The method of claim 28 , wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
24. The method of claim 18 , wherein the one or more PCR reaction components comprise one or more of: a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, or Mg++.
25. The method of claim 18 , comprising mixing the PCR reaction components with the sieving medium in a microfluidic channel.
26. The method of claim 25 , further comprising separating the one or more PCR products by flowing the one or more PCR products through the sieving medium in the microfluidic channel.
27. The method of claim 26 , wherein separating comprises electrophoretically separating.
28. A nucleic acid sieving medium, which medium comprises one or more polynucleotides, one or more PCR reagents, and a polymer solution, which polymer solution comprises less than about 0.5% polymer.
29. The sieving medium of claim 28 , wherein the polymer solution comprises less than about 0.4% polymer.
30. The sieving medium of claim 29 , wherein the polymer solution comprises about 0.35% polymer or less.
31. The sieving medium of claim 28 , wherein the polymer solution comprises acrylamide.
32. The sieving medium of claim 31 , wherein the acrylamide comprises linear acrylamide, polyacrylamide, polydimethylacrylamide, or polydimethylacrylamide/coacrylic acid.
33. The sieving medium of claim 28 , wherein the polymer solution comprises agarose, methyl cellulose, polyethylene oxide, hydroxycellulose, or hydroxy ethyl cellulose.
34. The sieving medium of claim 28 , wherein the one or more PCR reaction components comprise one or more of: a thermostable DNA polymerase, a plurality of nucleotides, a nucleic acid template, a primer which hybridizes to the nucleic acid template, or Mg++.
35. The sieving medium of claim 28 , wherein the one or more polynucleotides comprise DNA, RNA, or PCR products.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/792,297 US20020012971A1 (en) | 2000-03-20 | 2001-02-23 | PCR compatible nucleic acid sieving medium |
| US10/659,423 US7521186B2 (en) | 2000-03-20 | 2003-09-10 | PCR compatible nucleic acid sieving matrix |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19077300P | 2000-03-20 | 2000-03-20 | |
| US09/792,297 US20020012971A1 (en) | 2000-03-20 | 2001-02-23 | PCR compatible nucleic acid sieving medium |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/659,423 Division US7521186B2 (en) | 2000-03-20 | 2003-09-10 | PCR compatible nucleic acid sieving matrix |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20020012971A1 true US20020012971A1 (en) | 2002-01-31 |
Family
ID=26886426
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/792,297 Abandoned US20020012971A1 (en) | 2000-03-20 | 2001-02-23 | PCR compatible nucleic acid sieving medium |
| US10/659,423 Expired - Fee Related US7521186B2 (en) | 2000-03-20 | 2003-09-10 | PCR compatible nucleic acid sieving matrix |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/659,423 Expired - Fee Related US7521186B2 (en) | 2000-03-20 | 2003-09-10 | PCR compatible nucleic acid sieving matrix |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US20020012971A1 (en) |
Cited By (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060003439A1 (en) * | 2004-07-02 | 2006-01-05 | Ismagilov Rustem F | Microfluidic system |
| US20060014185A1 (en) * | 2004-06-29 | 2006-01-19 | Wallac Oy | Integrated nucleic acid analysis |
| US7001853B1 (en) | 2002-08-30 | 2006-02-21 | Caliper Life Sciences, Inc. | Flow control of photo-polymerizable resin |
| US20060153924A1 (en) * | 2003-03-31 | 2006-07-13 | Medical Research Council | Selection by compartmentalised screening |
| US20070092914A1 (en) * | 2004-03-31 | 2007-04-26 | Medical Research Council, Harvard University | Compartmentalised screening by microfluidic control |
| US20090020556A1 (en) * | 2007-07-19 | 2009-01-22 | Kabir James Mukaddam | Metering assembly and method of dispensing fluid |
| US20090197772A1 (en) * | 2004-03-31 | 2009-08-06 | Andrew Griffiths | Compartmentalised combinatorial chemistry by microfluidic control |
| US20090197248A1 (en) * | 2004-10-08 | 2009-08-06 | President And Fellows Of Harvard College | Vitro evolution in microfluidic systems |
| US20100022414A1 (en) * | 2008-07-18 | 2010-01-28 | Raindance Technologies, Inc. | Droplet Libraries |
| US20100078077A1 (en) * | 2006-12-19 | 2010-04-01 | Ismagilov Rustem F | Spacers for Microfluidic Channels |
| US20100163109A1 (en) * | 2007-02-06 | 2010-07-01 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US20100187452A1 (en) * | 2009-01-23 | 2010-07-29 | Formulatrix, Inc. | Microfluidic dispensing assembly |
| US20100210479A1 (en) * | 2003-03-31 | 2010-08-19 | Medical Research Council | Method of synthesis and testing of cominatorial libraries using microcapsules |
| US20100227767A1 (en) * | 2007-07-26 | 2010-09-09 | Boedicker James Q | Stochastic confinement to detect, manipulate, and utilize molecules and organisms |
| US20100233026A1 (en) * | 2002-05-09 | 2010-09-16 | Ismagliov Rustem F | Device and method for pressure-driven plug transport and reaction |
| US20100252118A1 (en) * | 2007-04-19 | 2010-10-07 | Seth Fraden | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| EP2302389A1 (en) * | 2002-05-09 | 2011-03-30 | The University of Chicago | Device and method for pressure-driven plug transport and reaction |
| US20110112503A1 (en) * | 2008-06-04 | 2011-05-12 | Ismagilov Rustem F | Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution |
| US20110223605A1 (en) * | 2009-06-04 | 2011-09-15 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
| US8528589B2 (en) | 2009-03-23 | 2013-09-10 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
| US8535889B2 (en) | 2010-02-12 | 2013-09-17 | Raindance Technologies, Inc. | Digital analyte analysis |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| US8961764B2 (en) | 2010-10-15 | 2015-02-24 | Lockheed Martin Corporation | Micro fluidic optic design |
| US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
| US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
| US9273308B2 (en) | 2006-05-11 | 2016-03-01 | Raindance Technologies, Inc. | Selection of compartmentalized screening method |
| US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
| US9328344B2 (en) | 2006-01-11 | 2016-05-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9415392B2 (en) | 2009-03-24 | 2016-08-16 | The University Of Chicago | Slip chip device and methods |
| US9447461B2 (en) | 2009-03-24 | 2016-09-20 | California Institute Of Technology | Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes |
| US9464319B2 (en) | 2009-03-24 | 2016-10-11 | California Institute Of Technology | Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US9562897B2 (en) | 2010-09-30 | 2017-02-07 | Raindance Technologies, Inc. | Sandwich assays in droplets |
| EP3092055A4 (en) * | 2014-01-09 | 2017-08-09 | The Board of Trustees of the Leland Stanford Junior University | Simultaneous extraction and separation of rna and dna from single cells using electrophoretic techniques |
| US10196700B2 (en) | 2009-03-24 | 2019-02-05 | University Of Chicago | Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| US10533998B2 (en) | 2008-07-18 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| US10837883B2 (en) | 2009-12-23 | 2020-11-17 | Bio-Rad Laboratories, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
| US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US12097475B2 (en) | 2004-07-02 | 2024-09-24 | The University Of Chicago | Microfluidic system |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6048734A (en) | 1995-09-15 | 2000-04-11 | The Regents Of The University Of Michigan | Thermal microvalves in a fluid flow method |
| US6692700B2 (en) | 2001-02-14 | 2004-02-17 | Handylab, Inc. | Heat-reduction methods and systems related to microfluidic devices |
| US7829025B2 (en) | 2001-03-28 | 2010-11-09 | Venture Lending & Leasing Iv, Inc. | Systems and methods for thermal actuation of microfluidic devices |
| US7323140B2 (en) | 2001-03-28 | 2008-01-29 | Handylab, Inc. | Moving microdroplets in a microfluidic device |
| KR100959101B1 (en) * | 2003-02-20 | 2010-05-25 | 삼성전자주식회사 | How to control the opening and closing of the inlet and outlet of the PCR reactor and the PCR reactor |
| US7820030B2 (en) * | 2003-04-16 | 2010-10-26 | Handylab, Inc. | System and method for electrochemical detection of biological compounds |
| EP2407243B1 (en) | 2003-07-31 | 2020-04-22 | Handylab, Inc. | Multilayered microfluidic device |
| US8852862B2 (en) | 2004-05-03 | 2014-10-07 | Handylab, Inc. | Method for processing polynucleotide-containing samples |
| CA2994321C (en) | 2004-05-03 | 2023-08-08 | Handylab, Inc. | A microfluidic device and methods for processing polynucleotide-containing samples |
| EP1637228A1 (en) * | 2004-09-16 | 2006-03-22 | Roche Diagnostics GmbH | Method an apparatus for performing rapid thermo cycling as well as a micro fabricated system |
| US10900066B2 (en) | 2006-03-24 | 2021-01-26 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
| US11806718B2 (en) | 2006-03-24 | 2023-11-07 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
| US8883490B2 (en) | 2006-03-24 | 2014-11-11 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
| WO2007112114A2 (en) | 2006-03-24 | 2007-10-04 | Handylab, Inc. | Integrated system for processing microfluidic samples, and method of using same |
| US7998708B2 (en) | 2006-03-24 | 2011-08-16 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
| WO2008061165A2 (en) | 2006-11-14 | 2008-05-22 | Handylab, Inc. | Microfluidic cartridge and method of making same |
| EP3222733B1 (en) | 2007-07-13 | 2021-04-07 | Handylab, Inc. | Polynucleotide capture materials, and methods of using same |
| US8133671B2 (en) | 2007-07-13 | 2012-03-13 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
| US9618139B2 (en) | 2007-07-13 | 2017-04-11 | Handylab, Inc. | Integrated heater and magnetic separator |
| US20090136385A1 (en) | 2007-07-13 | 2009-05-28 | Handylab, Inc. | Reagent Tube |
| US9186677B2 (en) | 2007-07-13 | 2015-11-17 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
| USD621060S1 (en) | 2008-07-14 | 2010-08-03 | Handylab, Inc. | Microfluidic cartridge |
| US8182763B2 (en) | 2007-07-13 | 2012-05-22 | Handylab, Inc. | Rack for sample tubes and reagent holders |
| US8287820B2 (en) | 2007-07-13 | 2012-10-16 | Handylab, Inc. | Automated pipetting apparatus having a combined liquid pump and pipette head system |
| US8105783B2 (en) | 2007-07-13 | 2012-01-31 | Handylab, Inc. | Microfluidic cartridge |
| USD618820S1 (en) | 2008-07-11 | 2010-06-29 | Handylab, Inc. | Reagent holder |
| USD787087S1 (en) | 2008-07-14 | 2017-05-16 | Handylab, Inc. | Housing |
| EP2440658B1 (en) * | 2009-06-12 | 2014-10-08 | Micronics, Inc. | Rehydratable matrices for dry storage of taq polymerase in a microfluidic device |
| CN106190806B (en) | 2011-04-15 | 2018-11-06 | 贝克顿·迪金森公司 | Scan real-time microfluid thermal cycler and the method for synchronous thermal cycle and scanning optical detection |
| CA2849917C (en) | 2011-09-30 | 2020-03-31 | Becton, Dickinson And Company | Unitized reagent strip |
| USD692162S1 (en) | 2011-09-30 | 2013-10-22 | Becton, Dickinson And Company | Single piece reagent holder |
| WO2013067202A1 (en) | 2011-11-04 | 2013-05-10 | Handylab, Inc. | Polynucleotide sample preparation device |
| EP2810080B1 (en) | 2012-02-03 | 2024-03-27 | Becton, Dickinson and Company | External files for distribution of molecular diagnostic tests and determination of compatibility between tests |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4390403A (en) | 1981-07-24 | 1983-06-28 | Batchelder J Samuel | Method and apparatus for dielectrophoretic manipulation of chemical species |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5135855A (en) * | 1986-09-03 | 1992-08-04 | The United States Of America As Represented By The Department Of Health And Human Services | Rapid, versatile and simple system for expressing genes in eukaryotic cells |
| US4908112A (en) | 1988-06-16 | 1990-03-13 | E. I. Du Pont De Nemours & Co. | Silicon semiconductor wafer for analyzing micronic biological samples |
| US5188963A (en) * | 1989-11-17 | 1993-02-23 | Gene Tec Corporation | Device for processing biological specimens for analysis of nucleic acids |
| US5264101A (en) | 1989-11-06 | 1993-11-23 | Applied Biosystems, Inc. | Capillary electrophoresis molecular weight separation of biomolecules using a polymer-containing solution |
| US5164055A (en) * | 1990-01-29 | 1992-11-17 | Applied Biosystems, Inc. | High-viscosity polymer matrix and methods |
| US5126022A (en) | 1990-02-28 | 1992-06-30 | Soane Tecnologies, Inc. | Method and device for moving molecules by the application of a plurality of electrical fields |
| US5770029A (en) | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
| US5750015A (en) | 1990-02-28 | 1998-05-12 | Soane Biosciences | Method and device for moving molecules by the application of a plurality of electrical fields |
| WO1992019960A1 (en) | 1991-05-09 | 1992-11-12 | Nanophore, Inc. | Methods for the electrophoretic separation of nucleic acids and other linear macromolecules in gel media with restrictive pore diameters |
| US5304487A (en) | 1992-05-01 | 1994-04-19 | Trustees Of The University Of Pennsylvania | Fluid handling in mesoscale analytical devices |
| US5587128A (en) | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
| US5498392A (en) | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
| US5637469A (en) | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
| RU2048522C1 (en) * | 1992-10-14 | 1995-11-20 | Институт белка РАН | Method of nucleic acid copying, method of their expression and a medium for their realization |
| US5874212A (en) | 1993-05-13 | 1999-02-23 | Thomas Jefferson University | Detection of single base mutations and other variations in double stranded DNA by conformation-sensitive gel electrophoresis |
| US5426039A (en) | 1993-09-08 | 1995-06-20 | Bio-Rad Laboratories, Inc. | Direct molecular cloning of primer extended DNA containing an alkane diol |
| US6001229A (en) | 1994-08-01 | 1999-12-14 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing microfluidic manipulations for chemical analysis |
| US5571410A (en) | 1994-10-19 | 1996-11-05 | Hewlett Packard Company | Fully integrated miniaturized planar liquid sample handling and analysis device |
| US5585069A (en) | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| US5603351A (en) | 1995-06-07 | 1997-02-18 | David Sarnoff Research Center, Inc. | Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device |
| US5856174A (en) * | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| US6395887B1 (en) * | 1995-08-01 | 2002-05-28 | Yale University | Analysis of gene expression by display of 3'-end fragments of CDNAS |
| US5716825A (en) | 1995-11-01 | 1998-02-10 | Hewlett Packard Company | Integrated nucleic acid analysis system for MALDI-TOF MS |
| US6399023B1 (en) | 1996-04-16 | 2002-06-04 | Caliper Technologies Corp. | Analytical system and method |
| US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
| US5942443A (en) | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
| AU726987B2 (en) | 1996-06-28 | 2000-11-30 | Caliper Life Sciences, Inc. | Electropipettor and compensation means for electrophoretic bias |
| US5779868A (en) | 1996-06-28 | 1998-07-14 | Caliper Technologies Corporation | Electropipettor and compensation means for electrophoretic bias |
| NZ333346A (en) | 1996-06-28 | 2000-03-27 | Caliper Techn Corp | High-throughput screening assay systems in microscale fluidic devices |
| US5800690A (en) | 1996-07-03 | 1998-09-01 | Caliper Technologies Corporation | Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces |
| US5699157A (en) | 1996-07-16 | 1997-12-16 | Caliper Technologies Corp. | Fourier detection of species migrating in a microchannel |
| US6447727B1 (en) | 1996-11-19 | 2002-09-10 | Caliper Technologies Corp. | Microfluidic systems |
| EP1959255A3 (en) | 1997-04-04 | 2008-09-24 | Caliper Life Sciences, Inc. | Closed-loop biochemical analyzers |
| US5964995A (en) | 1997-04-04 | 1999-10-12 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
| US5976336A (en) | 1997-04-25 | 1999-11-02 | Caliper Technologies Corp. | Microfluidic devices incorporating improved channel geometries |
| KR100351531B1 (en) | 1997-04-25 | 2002-09-11 | 캘리퍼 테크놀로지스 코포레이션 | Microfludic devices incorporating improved channel geometries |
| US6090251A (en) | 1997-06-06 | 2000-07-18 | Caliper Technologies, Inc. | Microfabricated structures for facilitating fluid introduction into microfluidic devices |
| US5869004A (en) | 1997-06-09 | 1999-02-09 | Caliper Technologies Corp. | Methods and apparatus for in situ concentration and/or dilution of materials in microfluidic systems |
| US6524790B1 (en) | 1997-06-09 | 2003-02-25 | Caliper Technologies Corp. | Apparatus and methods for correcting for variable velocity in microfluidic systems |
| US5882465A (en) | 1997-06-18 | 1999-03-16 | Caliper Technologies Corp. | Method of manufacturing microfluidic devices |
| US5959291A (en) | 1997-06-27 | 1999-09-28 | Caliper Technologies Corporation | Method and apparatus for measuring low power signals |
| US6001231A (en) | 1997-07-15 | 1999-12-14 | Caliper Technologies Corp. | Methods and systems for monitoring and controlling fluid flow rates in microfluidic systems |
| US5876675A (en) | 1997-08-05 | 1999-03-02 | Caliper Technologies Corp. | Microfluidic devices and systems |
| US5989402A (en) | 1997-08-29 | 1999-11-23 | Caliper Technologies Corp. | Controller/detector interfaces for microfluidic systems |
| US5965410A (en) | 1997-09-02 | 1999-10-12 | Caliper Technologies Corp. | Electrical current for controlling fluid parameters in microchannels |
| AU746098B2 (en) | 1997-09-02 | 2002-04-18 | Caliper Life Sciences, Inc. | Microfluidic system with electrofluidic and electrothermal controls |
| US6012902A (en) | 1997-09-25 | 2000-01-11 | Caliper Technologies Corp. | Micropump |
| US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
| US5958694A (en) | 1997-10-16 | 1999-09-28 | Caliper Technologies Corp. | Apparatus and methods for sequencing nucleic acids in microfluidic systems |
| US6074725A (en) | 1997-12-10 | 2000-06-13 | Caliper Technologies Corp. | Fabrication of microfluidic circuits by printing techniques |
| US5948227A (en) | 1997-12-17 | 1999-09-07 | Caliper Technologies Corp. | Methods and systems for performing electrophoretic molecular separations |
| US6430512B1 (en) | 1997-12-30 | 2002-08-06 | Caliper Technologies Corp. | Software for the display of chromatographic separation data |
| US6251343B1 (en) | 1998-02-24 | 2001-06-26 | Caliper Technologies Corp. | Microfluidic devices and systems incorporating cover layers |
| US6100541A (en) | 1998-02-24 | 2000-08-08 | Caliper Technologies Corporation | Microfluidic devices and systems incorporating integrated optical elements |
| US6123798A (en) | 1998-05-06 | 2000-09-26 | Caliper Technologies Corp. | Methods of fabricating polymeric structures incorporating microscale fluidic elements |
| US6306590B1 (en) * | 1998-06-08 | 2001-10-23 | Caliper Technologies Corp. | Microfluidic matrix localization apparatus and methods |
| WO2000009753A1 (en) | 1998-08-11 | 2000-02-24 | Caliper Technologies Corp. | Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
| US6445682B1 (en) * | 1998-10-06 | 2002-09-03 | Vertical Networks, Inc. | Systems and methods for multiple mode voice and data communications using intelligently bridged TDM and packet buses and methods for performing telephony and data functions using the same |
| US6455682B1 (en) | 1999-01-20 | 2002-09-24 | Northwestern University | DNA mobility modifier |
| US6632655B1 (en) | 1999-02-23 | 2003-10-14 | Caliper Technologies Corp. | Manipulation of microparticles in microfluidic systems |
| US6303343B1 (en) | 1999-04-06 | 2001-10-16 | Caliper Technologies Corp. | Inefficient fast PCR |
| US6495104B1 (en) | 1999-08-19 | 2002-12-17 | Caliper Technologies Corp. | Indicator components for microfluidic systems |
| WO2001016372A1 (en) * | 1999-08-27 | 2001-03-08 | Matrix Technologies Corporation | Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| WO2001069226A1 (en) * | 2000-03-10 | 2001-09-20 | Dna Sciences, Inc. | Cross channel device for serial sample injection |
| US6706162B1 (en) * | 2000-09-25 | 2004-03-16 | Applera Corporation | High speed, high resolution compositions, methods, and kits for capillary electrophoresis |
-
2001
- 2001-02-23 US US09/792,297 patent/US20020012971A1/en not_active Abandoned
-
2003
- 2003-09-10 US US10/659,423 patent/US7521186B2/en not_active Expired - Fee Related
Cited By (146)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8273573B2 (en) | 2002-05-09 | 2012-09-25 | The University Of Chicago | Method for obtaining a collection of plugs comprising biological molecules |
| US8304193B2 (en) | 2002-05-09 | 2012-11-06 | The University Of Chicago | Method for conducting an autocatalytic reaction in plugs in a microfluidic system |
| US20110177586A1 (en) * | 2002-05-09 | 2011-07-21 | The University Of Chicago | Device and method for pressure-driven plug transport |
| US20110177609A1 (en) * | 2002-05-09 | 2011-07-21 | The University Of Chicago | Device and method for pressure-driven plug transport |
| US10668471B2 (en) | 2002-05-09 | 2020-06-02 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US10118174B2 (en) | 2002-05-09 | 2018-11-06 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US9968933B2 (en) | 2002-05-09 | 2018-05-15 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US20110176966A1 (en) * | 2002-05-09 | 2011-07-21 | The University Of Chicago | Device and method for pressure-driven plug transport |
| US9592506B2 (en) | 2002-05-09 | 2017-03-14 | The University Of Chicago | Method of crystallization in aqueous plugs flowing in immiscible carrier-fluid in microfluidic system |
| US9579622B2 (en) | 2002-05-09 | 2017-02-28 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US11278898B2 (en) | 2002-05-09 | 2022-03-22 | The University Of Chicago | Method for conducting an autocatalytic reaction in plugs in a microfluidic system |
| US11413615B2 (en) | 2002-05-09 | 2022-08-16 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US10532358B2 (en) | 2002-05-09 | 2020-01-14 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US11413614B2 (en) | 2002-05-09 | 2022-08-16 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US10562028B2 (en) | 2002-05-09 | 2020-02-18 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US8889083B2 (en) | 2002-05-09 | 2014-11-18 | The University Of Chicago | Device and method for pressure-driven plug transport and reaction |
| US11478799B2 (en) | 2002-05-09 | 2022-10-25 | The University Of Chicago | Method for conducting reactions involving biological molecules in plugs in a microfluidic system |
| US8329407B2 (en) | 2002-05-09 | 2012-12-11 | The University Of Chicago | Method for conducting reactions involving biological molecules in plugs in a microfluidic system |
| US20100233026A1 (en) * | 2002-05-09 | 2010-09-16 | Ismagliov Rustem F | Device and method for pressure-driven plug transport and reaction |
| US9329107B2 (en) | 2002-05-09 | 2016-05-03 | The University Of Chicago | Device for pressure-driven plug transport comprising microchannel with traps |
| EP2278338A3 (en) * | 2002-05-09 | 2012-09-26 | The University of Chicago | Device and method for pressure-driven plug transport and reaction |
| US20110177494A1 (en) * | 2002-05-09 | 2011-07-21 | The University Of Chicago | Device and method for pressure-driven plug transport |
| EP2302389A1 (en) * | 2002-05-09 | 2011-03-30 | The University of Chicago | Device and method for pressure-driven plug transport and reaction |
| US20110142734A1 (en) * | 2002-05-09 | 2011-06-16 | The University Of Chicago | Device and method for pressure-driven plug transport |
| US20110174622A1 (en) * | 2002-05-09 | 2011-07-21 | The University Of Chicago | Device and method for pressure-driven plug transport |
| US7932190B2 (en) | 2002-08-30 | 2011-04-26 | Caliper Life Sciences, Inc | Flow control of photo-polymerizable resin |
| US20060121743A1 (en) * | 2002-08-30 | 2006-06-08 | Caliper Life Sciences, Inc. | Flow control of photo-polymerizable resin |
| US7001853B1 (en) | 2002-08-30 | 2006-02-21 | Caliper Life Sciences, Inc. | Flow control of photo-polymerizable resin |
| US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US9448172B2 (en) | 2003-03-31 | 2016-09-20 | Medical Research Council | Selection by compartmentalised screening |
| US9857303B2 (en) | 2003-03-31 | 2018-01-02 | Medical Research Council | Selection by compartmentalised screening |
| US20060153924A1 (en) * | 2003-03-31 | 2006-07-13 | Medical Research Council | Selection by compartmentalised screening |
| US10052605B2 (en) | 2003-03-31 | 2018-08-21 | Medical Research Council | Method of synthesis and testing of combinatorial libraries using microcapsules |
| US20100210479A1 (en) * | 2003-03-31 | 2010-08-19 | Medical Research Council | Method of synthesis and testing of cominatorial libraries using microcapsules |
| US11821109B2 (en) | 2004-03-31 | 2023-11-21 | President And Fellows Of Harvard College | Compartmentalised combinatorial chemistry by microfluidic control |
| US20070092914A1 (en) * | 2004-03-31 | 2007-04-26 | Medical Research Council, Harvard University | Compartmentalised screening by microfluidic control |
| US20090197772A1 (en) * | 2004-03-31 | 2009-08-06 | Andrew Griffiths | Compartmentalised combinatorial chemistry by microfluidic control |
| US9839890B2 (en) | 2004-03-31 | 2017-12-12 | National Science Foundation | Compartmentalised combinatorial chemistry by microfluidic control |
| US9925504B2 (en) | 2004-03-31 | 2018-03-27 | President And Fellows Of Harvard College | Compartmentalised combinatorial chemistry by microfluidic control |
| US8252536B2 (en) | 2004-06-29 | 2012-08-28 | Wallac Oy | Integrated nucleic acid analysis |
| US20110070585A1 (en) * | 2004-06-29 | 2011-03-24 | Wallac Oy | Integrated nucleic acid analysis |
| US20060014185A1 (en) * | 2004-06-29 | 2006-01-19 | Wallac Oy | Integrated nucleic acid analysis |
| US7776530B2 (en) * | 2004-06-29 | 2010-08-17 | Wallac Oy | Integrated nucleic acid analysis |
| US20060003439A1 (en) * | 2004-07-02 | 2006-01-05 | Ismagilov Rustem F | Microfluidic system |
| US9477233B2 (en) | 2004-07-02 | 2016-10-25 | The University Of Chicago | Microfluidic system with a plurality of sequential T-junctions for performing reactions in microdroplets |
| US12097475B2 (en) | 2004-07-02 | 2024-09-24 | The University Of Chicago | Microfluidic system |
| US9029083B2 (en) | 2004-10-08 | 2015-05-12 | Medical Research Council | Vitro evolution in microfluidic systems |
| US8871444B2 (en) | 2004-10-08 | 2014-10-28 | Medical Research Council | In vitro evolution in microfluidic systems |
| US9186643B2 (en) | 2004-10-08 | 2015-11-17 | Medical Research Council | In vitro evolution in microfluidic systems |
| US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
| US20090197248A1 (en) * | 2004-10-08 | 2009-08-06 | President And Fellows Of Harvard College | Vitro evolution in microfluidic systems |
| US9498759B2 (en) | 2004-10-12 | 2016-11-22 | President And Fellows Of Harvard College | Compartmentalized screening by microfluidic control |
| US20090005254A1 (en) * | 2004-10-12 | 2009-01-01 | Andrew Griffiths | Compartmentalized Screening by Microfluidic Control |
| US9328344B2 (en) | 2006-01-11 | 2016-05-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9410151B2 (en) | 2006-01-11 | 2016-08-09 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US9534216B2 (en) | 2006-01-11 | 2017-01-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US12146134B2 (en) | 2006-01-11 | 2024-11-19 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US11351510B2 (en) | 2006-05-11 | 2022-06-07 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US12337287B2 (en) | 2006-05-11 | 2025-06-24 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
| US12091710B2 (en) | 2006-05-11 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
| US9273308B2 (en) | 2006-05-11 | 2016-03-01 | Raindance Technologies, Inc. | Selection of compartmentalized screening method |
| US9498761B2 (en) | 2006-08-07 | 2016-11-22 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
| US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
| US20100078077A1 (en) * | 2006-12-19 | 2010-04-01 | Ismagilov Rustem F | Spacers for Microfluidic Channels |
| US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US10603662B2 (en) | 2007-02-06 | 2020-03-31 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US20100163109A1 (en) * | 2007-02-06 | 2010-07-01 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US9017623B2 (en) | 2007-02-06 | 2015-04-28 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
| US9440232B2 (en) | 2007-02-06 | 2016-09-13 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
| US11618024B2 (en) | 2007-04-19 | 2023-04-04 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US20100252118A1 (en) * | 2007-04-19 | 2010-10-07 | Seth Fraden | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US10675626B2 (en) | 2007-04-19 | 2020-06-09 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US10357772B2 (en) | 2007-04-19 | 2019-07-23 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US9068699B2 (en) | 2007-04-19 | 2015-06-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US11224876B2 (en) | 2007-04-19 | 2022-01-18 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US20090020556A1 (en) * | 2007-07-19 | 2009-01-22 | Kabir James Mukaddam | Metering assembly and method of dispensing fluid |
| US8016260B2 (en) | 2007-07-19 | 2011-09-13 | Formulatrix, Inc. | Metering assembly and method of dispensing fluid |
| US20100227767A1 (en) * | 2007-07-26 | 2010-09-09 | Boedicker James Q | Stochastic confinement to detect, manipulate, and utilize molecules and organisms |
| US9090885B2 (en) | 2007-07-26 | 2015-07-28 | The University Of Chicago | Co-incubating confined microbial communities |
| US20100317085A1 (en) * | 2007-07-26 | 2010-12-16 | Boedicker James Q | Co-incubating confined microbial communities |
| US8622987B2 (en) | 2008-06-04 | 2014-01-07 | The University Of Chicago | Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution |
| US20110112503A1 (en) * | 2008-06-04 | 2011-05-12 | Ismagilov Rustem F | Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution |
| US11534727B2 (en) | 2008-07-18 | 2022-12-27 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US10533998B2 (en) | 2008-07-18 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US20100022414A1 (en) * | 2008-07-18 | 2010-01-28 | Raindance Technologies, Inc. | Droplet Libraries |
| US11596908B2 (en) | 2008-07-18 | 2023-03-07 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
| US20100186841A1 (en) * | 2009-01-23 | 2010-07-29 | Formulatrix, Inc. | Microfluidic dispensing assembly |
| US8100293B2 (en) | 2009-01-23 | 2012-01-24 | Formulatrix, Inc. | Microfluidic dispensing assembly |
| US20100187452A1 (en) * | 2009-01-23 | 2010-07-29 | Formulatrix, Inc. | Microfluidic dispensing assembly |
| US8550298B2 (en) | 2009-01-23 | 2013-10-08 | Formulatrix, Inc. | Microfluidic dispensing assembly |
| US8528589B2 (en) | 2009-03-23 | 2013-09-10 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
| US12352673B2 (en) | 2009-03-23 | 2025-07-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
| US11268887B2 (en) | 2009-03-23 | 2022-03-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
| US9447461B2 (en) | 2009-03-24 | 2016-09-20 | California Institute Of Technology | Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes |
| US10543485B2 (en) | 2009-03-24 | 2020-01-28 | University Of Chicago | Slip chip device and methods |
| US9493826B2 (en) | 2009-03-24 | 2016-11-15 | California Institute Of Technology | Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes |
| US10370705B2 (en) | 2009-03-24 | 2019-08-06 | University Of Chicago | Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes |
| US9464319B2 (en) | 2009-03-24 | 2016-10-11 | California Institute Of Technology | Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes |
| US9415392B2 (en) | 2009-03-24 | 2016-08-16 | The University Of Chicago | Slip chip device and methods |
| US10196700B2 (en) | 2009-03-24 | 2019-02-05 | University Of Chicago | Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes |
| US20110223605A1 (en) * | 2009-06-04 | 2011-09-15 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
| US9067207B2 (en) | 2009-06-04 | 2015-06-30 | University Of Virginia Patent Foundation | Optical approach for microfluidic DNA electrophoresis detection |
| US20110229897A1 (en) * | 2009-06-04 | 2011-09-22 | Lockheed Martin Corporation | Optical approach for microfluidic DNA electrophoresis detection |
| US9656261B2 (en) | 2009-06-04 | 2017-05-23 | Leidos Innovations Technology, Inc. | DNA analyzer |
| US9649631B2 (en) | 2009-06-04 | 2017-05-16 | Leidos Innovations Technology, Inc. | Multiple-sample microfluidic chip for DNA analysis |
| US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| US10837883B2 (en) | 2009-12-23 | 2020-11-17 | Bio-Rad Laboratories, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
| US9074242B2 (en) | 2010-02-12 | 2015-07-07 | Raindance Technologies, Inc. | Digital analyte analysis |
| US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US8535889B2 (en) | 2010-02-12 | 2013-09-17 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US10808279B2 (en) | 2010-02-12 | 2020-10-20 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9228229B2 (en) | 2010-02-12 | 2016-01-05 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9562897B2 (en) | 2010-09-30 | 2017-02-07 | Raindance Technologies, Inc. | Sandwich assays in droplets |
| US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
| US8961764B2 (en) | 2010-10-15 | 2015-02-24 | Lockheed Martin Corporation | Micro fluidic optic design |
| US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
| US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12140590B2 (en) | 2011-02-18 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11747327B2 (en) | 2011-02-18 | 2023-09-05 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US12140591B2 (en) | 2011-02-18 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11768198B2 (en) | 2011-02-18 | 2023-09-26 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
| US11965877B2 (en) | 2011-02-18 | 2024-04-23 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
| US11754499B2 (en) | 2011-06-02 | 2023-09-12 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
| US9988676B2 (en) | 2012-02-22 | 2018-06-05 | Leidos Innovations Technology, Inc. | Microfluidic cartridge |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
| US10750928B2 (en) | 2014-01-09 | 2020-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Simultaneous extraction and separation of RNA and DNA from single cells using electrophoretic techniques |
| EP3092055A4 (en) * | 2014-01-09 | 2017-08-09 | The Board of Trustees of the Leland Stanford Junior University | Simultaneous extraction and separation of rna and dna from single cells using electrophoretic techniques |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| US7521186B2 (en) | 2009-04-21 |
| US20040045827A1 (en) | 2004-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7521186B2 (en) | PCR compatible nucleic acid sieving matrix | |
| US7156969B2 (en) | Microfluidic matrix localization apparatus and methods | |
| Kan et al. | DNA sequencing and genotyping in miniaturized electrophoresis systems | |
| Legendre et al. | A simple, valveless microfluidic sample preparation device for extraction and amplification of DNA from nanoliter-volume samples | |
| Zhang et al. | Automated and integrated system for high-throughput DNA genotyping directly from blood | |
| CN103328981B (en) | Systems and methods for automated reusable parallel biological reactions | |
| Shintaku et al. | On-chip separation and analysis of RNA and DNA from single cells | |
| WO2008052138A9 (en) | Inline-injection microdevice and microfabricated integrated dna analysis system using same | |
| JP2020535951A (en) | How to make a monodisperse emulsion | |
| Le Roux et al. | DNA analysis using an integrated microchip for multiplex PCR amplification and electrophoresis for reference samples | |
| US20090211908A1 (en) | Devices and methods for detecting and quantitating nucleic acids using size-separation of amplicons | |
| US20100184020A1 (en) | Chip-Based Sequencing Nucleic Acids | |
| JP2021534956A (en) | Droplet formation induced by monodisperse particles from a stable jet | |
| Sassi et al. | Rapid, parallel separations of D1S80 alleles in a plastic microchannel chip | |
| US11365411B2 (en) | Efficient random access to DNA-encoded data | |
| Wang et al. | Bare nanocapillary for DNA separation and genotyping analysis in gel-free solutions without application of external electric field | |
| Ng et al. | Miniaturized platforms for the detection of single-nucleotide polymorphisms | |
| Snider et al. | A microfluidics workflow for sample preparation for next-generation DNA sequencing | |
| Njoroge et al. | Integrated continuous flow polymerase chain reaction and micro‐capillary electrophoresis system with bioaffinity preconcentration | |
| Malic et al. | Current state of intellectual property in microfluidic nucleic acid analysis | |
| Hatori et al. | Dual‐layered hydrogels allow complete genome recovery with nucleic acid cytometry | |
| Ugaz et al. | Electrophoresis in microfluidic systems | |
| Mikšík | Capillary gel and sieving electrophoresis | |
| Kopp et al. | Continuous flow PCR on a chip | |
| Xie et al. | Microchip-based capillary electrophoresis systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: CALIPER TECHNOLOGIES CORP., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEHTA, TAMMY BURD;REEL/FRAME:012101/0832 Effective date: 20010715 |
|
| STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |